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1047-103 Correlation of Biochemical and Echocardiographic 
Indicators of Valvular Dysfunction in Dilated 
Cardiomyopathy 
Kathryn J. Grande-Allen, Brian P. Griffin, Joseph Holcomb, Ivan Vesely. C/eve/and Clinic 
Foundation, Cleveland, OH 
Background: Left ventricular dilatation in dilated cardiomyopathy (DCM) is associated 
with mitral regurgitation even in the absence of gross morphological changes in the mitral 
valve. We sought to determine whether the anatomic changes and measures of vakular 
dysfunction resulting from DCM are asswated with biochemical changes in the mitral 
valve. Methods: Mitral valves were obtaned from 14 hearts with DCM immediately foi- 
lowing transplant. DNA, collagen, glycosaminoglycan (GAG), and water concentration 
were compared with 12 autopsy controls. Valvular function and cardiac dimensions were 
measured from the preoperative echocardiograms, and compared with biochemical 
parameters via univariate analysis. Results: The mitral leaflets had significantly less 
DNA than normal controls, while both the leaflets and chordae had significantly fewer 
GAGS. In both leaflets and chord+ percentage water was inversely correlated with 
annular diameter (r = -0.70), left atrial diameter (I = -0.77), left atriai area (I = -0.81), left 
ventricular systolic volume (r = -0 67), and anterior leaflet length (r = -0.80). The reduced 
leaflet GAGS were associated with reduced septal wall thickness (r = 0.58) and mcreased 
left atrial area (r = -0.70). Collagen concentration was associated with anterior leaflet 
length (r = 0.74) and grade of mitral regurgitation (r = 0.63). All correlations were slgnifi- 
cant at pcO.05. Conclusion: Despite the apparently normal morphology of mitral valves 
in failing hearts with DCM, we found that there are significant alterations in the biochemi- 
cal makeup of the mitral leaflets and chordae Furthermore, these alterations are highly 
correlated with measured changes I” cardiac and valvular dimensions and function. 
These findings suggest that the mitral leaflets and chordae undergo remodeling in 
response io changes in their functional environment. 
Biochemical parameters for leaflets (L) and chordae (C). *pcO.O5 vs. control. 
L: % water 
c: % water 
L: GAGS (mg/g wet wt) 
6: GAGS (mg/g wet wt) 
L: DNA (mg/g dry wt) 
C: DNA (mgig dry wt) 
L: collagen (% of dry wt) 
C: collage” (% of dry wt) 
Control DCM 
85.054.7 88 4~2.6 
79.3k5.2 76.4k5.7 
864&546 759t396 * 
8361t365 1035+702 * 
25531t728 3037r1209’ 
1941 k762 1707i714 
52.3i10.8 55.2i-17.4 
67.8~11 .l 64.0216.2 
1047-104 Detection of Mitral Annular Calcium on Fast Dual Spiral 
Computed Tomography Is Associated With Advanced 
Coronary Artery Disease in Hypertensive Patients 
Yehuda Adler, Joseph Shemesh, Alexander Tenenbaum, Noam Fink, Boaz Hovav, 
Enrique Z. Fisman, Michael Metro. Cardiac Rehabilitation, Tel Hashomer, Israel 
Background:- Mitral annulus calcification (MAC) may be a form of atherosclerosis and 
may lead to serious clinical consequences. The aim of the present study was to Investi- 
gate whether an association between the presence and severity of MAC and advanced 
coronary calcium (CC) exists in hypertensive patients with increased cardiovascular risk 
as detected on double-helical CT (DHCT). 
Methods: 268 hypertensive patients participants of the INSIGHT study in our region 
were included (131 men; mean age 73+4 years). Ail underwent DHCT of the heart for CC 
scoring. Detection of CC was based on the presence of at least one lesion with an area 
of >0.5mm2, and CT density above 90 Hounsfield units (total CC score>O). MAC was 
defined on DHCT as any detected calcification in the region of the mitral annulus. 
Results: MAC was documented in 51 patients (29 men; mean age 74?4 years). The age 
and sex matched non-MAC group @x&l) included 217 patients (102 men; mean age 
73+4 years). There were no intergroup differences in risk factors for atherosclerosis. A 
significant association was found between the presence of MAC and advanced CC (total 
calcium score >300) compared with the control (35% vs. 15%, p=O.OOl), between the 
presence of MAC and mean CC score (4572760 vs. 148i317,p=O.O4), between the pres- 
ence of MAC and proven coronary artery disease (31% vs. 17%, p=O.O16), and between 
the groups for the presence of 3 vessel disease (41% V.S. 22%,p=O.O05). Multivariate 
analysis identified MAC and smoking as the only independent variables associated with 
coronary artery disease (p=O.Ol and p=O.O3, respectively), and MAC and sex as the only 
independent variables associated with CC (p=O.OOOl and p=O.O07, respectively). 
Conclusions: Our study demonstrated an association between the presence and sever- 
ity of MAC and advanced CC on DHCT, and between MAC, documented on DHCT, with 
Proven coronary artery disease. 
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1047-105 The Effect of Changing Trends in Endocarditis on Outcomes 
Christopher H. &bell, Gail E. Peterson, Vance 6. Fowler, Jr., Deverick J. Anderson, 
Christopher W. Woods, G. R. Corey, Daniel J. Sexton, Thomas Ryan. Duke Universify 
Medical Center, Durham, NC, Duke Clinical Research Institute, Durham, NC 
Background: Endocardltis has classically been described as a disease of cardiac pre- 
disposition and community acquired bacteremia. Recent evidence indicates there are 
additional contributing factors. We have previously shown that over the last 10 years Sta- 
phylococcus aureus (S. aureus) endocardltis has significantly mcreased in frequency. In 
addition, hemodialysis and immune suppression have become more prevalent. We 
sought to determine whether these changing trends affect patient outcome. Methods: 
From l/l/91 to 12/31/99 we identified 450 cases of definite or possible endocarditis as 
defined by the Duke criteria. Clinical, laboratory and echocardiographic data were col- 
&ted on each patient. Logistic regression analyses were used to determine the echo 
predictors of stroke and surgery. Logistic regresslo” and Cox proportional hazard model- 
ing were used to examine the relationships between changing trends in endocarditis and 
the rates of stroke, surgery, 30 day and one year mortality. Results: Over the 10.year 
period, the 30 day mortality rate for those with endocarditis remained unchanged, at 
15.8%, while one year mortality (38% overall) had a decreasing trend over time (p<O.Ol). 
In a multivariate analysis, the only independent predictor of 30 day mortality was age. 
The independent predictors of one year mortality were immune suppression, S. aureus, 
age and stroke (pcO.03). Stroke occurred in 12.7% of patients, and did not change over 
time. The rate of surgery (16.2% overall) had a decreasing trend over time (p=O.O4). In 
the multlvariate analysis, the only characteristic that independently predicted surgery 
was intracardiac abscess (p=O.Ol) while a history of hemodialysis (p=O.OZ) and S. 
aureus infection predicted medical therapy (p<O.Ol). Conclusion: Despite an increase in 
S. aureus and immune suppression in endocarditis patients, both associated with 
increased mortality, the overall one year mortality has decreased. These findings may 
reflect improvements in diagnostic criteria, technology and knowledge of the disease, 
which may lead to earlier diagnosis and more appropriate therapy. 
1047-106 Value of Echocardiography in Evaluation of Murmurs and 
Suspected Valvular or Congenital Heart Disease at a 
University Based Teaching Hospital: a IO-Year Experience 
Sharad Bansal, Avinash Khanna, Alan D. Forker. University of Missouri Kansas City 
School of Medicine, Kansas Citv MO 
Background : Despite recommendations by several authors and organizations regarding 
evaluation of murmurs and suspected valvular or congenital heart disease, there is lim- 
ited objective data on role of echocardiography for evaluating the presence and severity 
of significant valvular (VHD) and/or congenital heart disease (CHD) in the adult. In this 
era of cost-containment, we hypothewed that echocardiography is overutilized with poor 
diagnostic yield. 
Methods : We retrospectively reviewed the echocardiography database at our hospital 
over the last 10 years without knowledge of clinical data. Transthoracic echocardiograms 
requested for evaluation of murmur and suspected VHDiCHD were included in the study. 
Patients were excluded if they had documented VHD or CHD, prosthetic valves, or were 
being evaluated for acute Infective endocarditis. Valvular lesions were classified by the 
original readers as normal, mild, mild-moderate, moderate, moderate-severe and severe 
on the basis of structural and Doppler data. No clinical data was utilized. 
Results : 1042 patients met the above criteria from 1990-1999. Mean age was 54 t 18 
years (range 14-100). There were 734 (70.7%) women and 308 (29.3%) men. Out of 
these, 206 (19.7%) patients had moderate or greater valvular or congenital abnormality 
to account for the murmur. Only 65 (6.2%) patients had moderate-severe or severe 
lesions. 43 (3.5%) patients had congenital heart disease. Moderate or greater valvular 
IeSiOns were as follows: tricuspid regurgitation (63 or 6.0%), mitral regurgitation (57 or 
5.5%), aortic stenosis (47 or 4.5%), aortic regurgitation (36 or 3.4%) & mitral stenosis (4 
dr 0.4%). There were 3 cases of pulmonic stenosis & no case of tricuspid stenosis. 
Conclusions : This study demonstrates that echocardiographically significant valvular 
pisease or congenital abnormalities are present in a small subgroup of patients undergo- 
ing transthoracic echocardiography with Doppler for evaluation of a murmur. We suggest 
more rigorous clinical triage of patients before ordering an echocardiogram to improve 
the cost-benefit ratio. 
1047-107 Collagenase Activity Selectively increases in Aortic 
Regurgitation to Suppress Collagen Content in Fibrosis 
Sharada L. Truter, Jennifer A. Lee, Themy F. Dumlaa, Jr., Karin Young, Jeffrey S. Borer. 
Wei// Medical Coilege of Come// University, New York, NY 
Background: We have shown hyperproduction of glucosamine-containing matrix, includ- 
ing fibronectin, and normal (nl) collagen content in aortic regurgitant (AR) hearts despite 
myocardial fibrosis. Though fibronectin gene expression is upregulated and collagen iso- 
form gene expression appears nl, the role of degradative metalloproteinases (MMP) in 
shaping AR fibrosis is not known. Therefore, we assessed MMP-2.collagenase and 
fibronectinase activity in cardiac fibroblasts (CF) from nl vs surgically-induced chronic AR 
NZW rabbit hearts. To determine if findings resulted directly from mechanical stresses, 
we also studied CF from nl rabbit hearts exposed to exogenous mechanical stram model- 
ing that of AR. Methods: Triplicate CF cultures were prepared from each of 3 paired AR 
(R fractians=ld%, 25% and 38%) and nl rabbits. Also, triplicate CF cultures from 3 nl rab- 
bits were divided for growth during mechanical strain (O-10% and IO-25%) applied in cul- 
ture at 60 cycleslmin and without strain. Zymograms were prepared by separating 
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Conclusion: Chronic AR and AR-like mechanical strain of nl-CF activate collagenase 
but not fibronectinase. Thus, MMP-2 change may result drrectly from CF strain in AR. 
MMP variation may help to explain selective relative collagen deficit observed in AR- 
induced fibrosis. 
1049-103 Prevention of Progressive Left Ventricular Dilation With the 
Acorn Cardiac Support Device Downregulates Stretch- 
Response Proteins and Improves Sarcoplasmic Reticulum 
Calcium Cycling in Dogs With Chronic Heart Failure 
1047-108 Impaired Elastic Properties of the Aortic Root in Patients Hani N. Sabbah, Ramesh C. Gupta, Victor G. Sharov, Anastassia Todor, Sudhish Mishra, 
With Bicuspid Aortic Valve Pervaiz A. Chaudhry, George Suzuki. Henry FordHealth System, D&roil, MI 
Stefano Nistri, Maria D. Sorbo, Cristina Basso, Gaetano Thiene. Medical Service, Arma 
dei Carabinieri., Padova, /ta/~ Dpmt. of Pathology - University of Padua, Padova, My 
Background: Bicuspid aortic valve (BAV) is frequently associated with clinically relevant 
abnormalities of the aorta, suggesting the existence of a common underlying develop- 
mental defect involving both the aortic valve and the wall of the ascending aorta. To date, 
aortic dilatation has been considered to be a clinical correlate of aortic medial weakness. 
The present study was aimed to evaluate the elastic properties of the aortic root in 49 
young males with normally functioning (18) or mildly regurgitant (31.) BAV. Methods: Dis- 
tensibility and stiffness index were calculated as a function of changes in aortic diameter 
and pulse pressure; aortic diameters were measured by echocardiography, and blood 
pressure was measure by a cuff sphygmomanometer. Data were compared with those 
from 44 normal subjects, matched for gender and age. Results: Patients and controls 
were comparable for body surface area (1.9+/-0.1 vs 1.87+/-0.1 m2, respectively), sys- 
tolic (125+1-5 vs 126+i-4 mmHg, respectively), and diastolic blood pressure (74.8+/-6 vs 
74.6+/-6 mmHg respectively). Measurements made by means of 2-D echocardiography 
showed that patients with BAV had significantly larger aortic root dimensions at annulus 
(24+1-2, vs 22+/-2 mm, p<O.OOl), at Valsalva’s sinuses (33+/-4 vs 26+/-3 mm, P<O.OOl), 
at sine-tubular junction (29+/-3 vs 25+/-2 mm, PcO.001) and at proximal ascending aorta 
(28+//-3, vs 25 +/- 2 mm, P<O.OOl). The difference between systolic and diastolic diame- 
ter of the aortic root was significantly lower in patients than in controls (2,l +/- I,2 cm vs. 
3 +I- 1 ,l cm, respectively, P<O.OOi). In patients and controls both aortic distensibility (2.7 
+I- 1.5 vs 4.86 +/- 2.18 x 10-6 cm2/dyne-I, respectively P ~0.001) and aortic stiffness 
index (10.2 +/- 5.3 vs 5.03 +/- 1.97, respectively ,P< 0.001) were significantly different, 
showing impaired elastic properties of the ascending aorta in patients with BAV. Conclu- 
sions: Patients with BAV and no or mild aortic regurgitation present larger aortic root 
size, and abnormal elastic properties of the ascending aorta, confirming the notion that 
aortic root dilatation is a morphological correlate of intrinsic medial weakness of the 
ascending aorta. 
Background: In the seeing of LV dysfunction, progressive LV dilation leads to cardi- 
omyocyte (CM) stretch that can trigger CM hypertrophy with subsequent impairment of 
sarcoplasmic reticulum (SR) calcium cycling and worsening LV function. We previously 
showed that in dogs with HF, chronic therapy with the Acorn Cardiac Support Device 
&SD), a preformed polyester mesh surgically placed around the ventricles, prevents pro- 
gressive LV dilation, attenuates CM hypertrophy and improves systolic and diastolic LV 
function. 
Methods: In this study, LV tissue from 6 control untreated HF dogs and 6 HF dogs 
treated for 3 months with CSD was used to examine the expression of p21ras, c-fos and 
MAPK p38 aij3, cell-stretch response proteins that activate signaling pathways which can 
induce hypertrophy. We also examined SR Ca’+-ATPase activity (fun01 Pi released/mini 
mg protein) “sing the calorimetric method. Tissue from 6 normal (NL) dogs was used for 
comparison. Tissue homogenate was used for Western blots and bands were quantified 
in densitometric “nits. 
Results: The results are shown in the table. 
NL HF.untreated HF + CSD 
p2 1 ras 1.2kO.2 4.7 + 0.8’ 1.8~0.5A 
c-fos 2.0 + 0.2 4.9 i 1 .o* 1.7*0.3” 
MAPK ~38 aiS 5.8 t 0.3 15.3+1.9 6.5 + 0.5” 
Ca”+-ATPase activity 0.19 * 0.01 0.13 r 0.01’ 0.21 * 0.02A 
*=P<O.O5 vs. NL; “=PcO.O5 vs. HF.untreated 
1047-109 Predictors of Mortality in 560 Patients With Infective 
Endocarditis: Findings of the Multicentre Aspirin Trial in 
Infective Endocarditis (MATIE) Study 
p2lras c-fos and MAPK p38 aig increased in untreated HF dogs compared to NL but 
were similar to NL in CSD-treated dogs. Ca et-ATPase activity, at low Caa+ (0.4 urn), was 
reduced in untreated HF dogs compared to NL but increased significantly in CSD-treated 
dogs compared to untreated HF dogs. 
Conclusions: Preventing progressive LV dilation with the Acorn CSD in dogs with HF 
attenuates CM stretch, as evidenced by downregulation of stretch response proteins, and 
improves SR Ca2+ cycling. These features, when viewed in concert, offer an explanation 
for the observed improvement of global LV systolic and diastolic function seen with 
chronic CSD therapy. 
Kwan-Leung Ghan, Jean G. Dumesnil, Bibiana Cujec, Anthony Sanfilippo, John Jue, 
Trevor Robinson. University of Oltawa Heart Institute, Ottawa, ON, Canada 
1049-104 Is Clamping of the Aorta Safer Than Occlusion With a 
Balloon? 
J&o Mela, Rosa H. Gouveia, Ana R Martins. Santa Cruz Hospital, Carnaxide, Portugal 
Background: Despite advances in surgical and medical treatment, the mortality of 
infective endocarditis (IE) remains high. Methods: To assess the determinants of in-hos- 
pital mortality, we analysed the database of the Multicentre Aspirin Trial in Infective 
Endocarditis study which was prospectively collected between July 1994 and June 1998 
in 14 centres. Among 560 patients (pts) with IE, 85 pts died (15.2%), with the main 
causes of death being sepsis in 44 (52%) heart failure in 24 (28%) and shock in 16 
(19%). The mean age was 54+28 years and 211 (38%) were women. 
Results: 
Findings Dead (11=85x) Alive (w475) P 
prosthetic valve IE 25 91 0.04 
Background: Because the use of aortic endoluminal balloons to occlude the aorta has 
recently been introduced, we compare its damaging effects with those of a conventional 
surgical clamp. Methods: Segments of human aorta were harvested from cadavers 
within 24 hours of death. The donors’ age ranged from 23 months to 77 years. The seg- 
ments were divided in 3 groups according to the degree of atherosclerosis: none or mild 
(group A, n=4), moderate (group B, n=12) and severe (group C, n=6). Each segment was 
clamped, at 3cm intervals, with an Edwards clamp (at a pressure of 150 mm Hg) and 
occluded with a balloon (filled at 300mm Hg). After 5 minutes of clamping, stereomicro- 
scopic and histological evaluations were performed. Results: There was no documented 
damage in group A regardless of the occlusion method. Five segments in group B 
showed lesions, 4 with clamp and 1 with balloon. Two clamp lesions were limited to the 
intima and two extended to the inner third of the media. The only balloon lesion was a 
rupture of the fibrous cap of a large lipid rich plaque. Due to gross destruction, and irre- 
spectively of the occlusion method, evaluation of group C specimens was inconclusive. 
Conclusions: In normal or mildly atherosclerotic aortas the two methods show no differ- 
ences, whereas moderately atherosclerotic aortas appear to be less damaged when 
occluded with endoluminal balloons. 
new or changing murmur 62 351 NS 
right-sided IE 14 81 NS 
native valve disease 45 233 NS 
aortic stenosis 16 34 0.001 
aortic regurgitation 25 100 NS 
mitral regurgitation 24 100 NS 
IV drug abuse 13 121 0.01 
prior IE 8 48 NS 
dyspnea 61 216 0.0001 
confusion 37 88 0.0001 
positive echo 77 394 NS 
perivalvular abscess 7 37 NS 
Among the complications, heart failure, renal dysfunction and major bleeding but not 
embolism predicted mortality (P=O.OOOl). Surgery performed in 196 pts (35%) had an 
in-hospital mortality of 10% and was a predictor for survival (P=O.OOZ). 
Conclusions: Predictors for mortality in IE include prosthetic valve IE, confusion or dysp- 
nea on admission, and the development of heart failure, renal dysfunction and bleeding; 
whereas surgery improves survival. 
1049-105 Impact of the Device Based Shape Change on Left 
Ventricular Diastolic Function in a Pacing induced 
Cardiomyopathy Model 
Tomotsugu Tabata, Kiyotaka Fukamachi, Masami Takagaki, Lisa A. Cardon, Yoshie 
Ochiai, Kazuyoshi Doi, Patric M. McCarthy, Cyril J. Schweich, Jr., Todd J. Mortier, 
Richard F. Schroeder, James D. Thomas. The Cleveland Clinic Foundation, Cleveland, 
OH, Myocor Inc., Plymouth, MN 
Background: We previously reported that left ventricular (LV) shape change using a 
novel device, the Myocor” Myosplint@ , produced significant increases in LV systolic 
function in a pacing induced canine cardiomyopathy model. 
Purpose: We evaluated the acute impact of shape change produced by the implantation 
of Myosplint on LV diastolic function “sing a canine cardiomyopathy model. 
JACC February 2001 
Methods: Heart failure was induced in 6 healthy mongrel dogs by rapid ventricular pac- 
ing (230 bpm) for an average of 28 days. To achreve a reduction ~n effectrve LV radius and 
a commensurate reduction in wall stress, 3 Myospknt devrces were implanted perpendic- 
ular to the LV long axis and by drawing the opposing LV walls inward, creating a symmet- 
rrc bilobular LV. The LV diastolic functron was evaluated hemodynamically by examining 
the mrnimal rate of LV pressure change (“in dP/dt), before and after implantatron of the 
devices. The early (E) and late (A) diastolic mitral inflow velocities, therr ratio (E/A), and 
the deceleration time of E wave (DT) as well as the color M-mode Doppler flow propaga- 
tion velocity (V,) were obtained echocardiographically. 
Results: f) After MyosplintT” Implantation. there was no significant change in the LV 
end-drastolic (19 3 vs 21.4 mm Hg), or mean left atrial (14.1 vs 16.5 mm Hg) pressures or 
heart rate. 2) The min dP/dt showed a trend (p=O.i2) to increase (809 vs 968 mm Hg/ 
set), whereas the mitral inflow Doppler velocities, which showed “pseudonormalization” 
at the baseline, did not change significantly and VP remained low after implantation of the 
device. 
Conclusion: LV shape change produced by the Myocor Myosplrnt may potentially 
improve the rate of lsovolumic LV relaxation. Although LV systolic function improves, 
there seems to be no adverse effect on diastolic function by the Myocor device. 
VP (cm/s) E(cmis) A(cm/s) E/A DT (msec) 
Baseline 22.&3.9 67i8 37+9 1 .sr0.4 86+21 
Treated 25.61-3.6 63r6 3423 1 .si-0.2 102124 
p value “S “S ns “S ns 
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1049-108 Current Operative Risk of Isolated and Combined Valvular 
Heart Surgery in Octogenarians 
Yan Katsnelson, Thomas B. Graboys, Robert J. Rizzo, David H. Adams, Lawrence H. 
Cohn. Bngham and Women’s Hospital, Boston. MA 
Background: The number of patients 2 eighty years of age referred for valve surgery 
continues to increase and will become a major referral source in the next decade. There- 
fore, it is Important to assess tne results of the current operative treatment and to define 
surgical risks in this age group. Methods: 409 consecutive patients 2 eighty years of age 
underwent isolated or combined elective and emergent valve surgery at Brigham and 
Women’s Hospital from 111995 to 3/2000. Aortic valve replacement surgery was per- 
formed in 246 patients (60%), mitral valve replacement surgery was done rn 118 
patients(ZS%) and double valve replacement surgery was done in 45 patients (11%). 
Concomitant coronary, artery bypass grafts were done in 61% of aortic, 64% of mitral. 
and 80% double valve operations. New York Heart Association Class Ill-IV symptoms 
were present in 58% of the patients, 13% were moperations and 23% had a left ventricu- 
lar ejection fraction < 0 40. Multivariate analysis of risk factorsjncluding preoperative left 
ventricular function and Comorbidities, were carried out. Results: Overall, operative mor- 
talrty was 7.6% (311409); 5.2% for isolated aortic valve replacement, 7% for mitral valve 
replacement and 11% for double valve replacment. For valve replacement combined with 
coronary artery bypass grafting the operative mortality was S%, 8% and 8% respectively. 
Multivariate analysis indicated preoperative renal failure and diabetes mellitus were pre- 
dictive of early mortality, but left ventricular, function, reoperations or coronary artery 
bypass grafting were not. Age Itself was not a risk factor, but patrents > 85 had more neu- 
rologic events. Only 33% of patients had no postoperative complications, but the median 
length of stay was 9 days (4.56) and the median intensive care unit stay was 2 days. 
Conclusion: Valve operations wrth or without coronary artery bypass grafting rn patients 
t 80 years of age can be performed with acceptable early morbidity and mortality and 
should be offered to patients in this age group with otherwise appropriate rndicatione for 
surgery and in particular, preserved renal function. 
1049-109 The Mechanisms of Aortic Valve Opening and Closure 
Emmanuel Lansac, Hou Sen Lim, Yu Shomura, Nolan T. Rice, Khee Hiang Lim, Joon 
Hock Yea, Christophe Acar, James H. Oury, Carlos M. G. Duran. lnfernafional Heart 
institute Of Montana Founadation, Mrssoula, MT 
Background: The mechamsms of aortic valve opening and closure are controversial. A 
study of the aortic valve dynamics was conducted using 3-D high sampling rate sonomi- 
crometry (up to 800Hz). Methods: Eighteen crystals were implanted in 8 sheep at each 
annular base (3), commissures (3), Sinus of Valsaiva (3) crest of the sinotubular junction 
(3), nodulus Arantius of the leaflets (3) and ascending aorta (3) Under stable hemody- 
namic conditions, changes in distances and areas were time-related to left ventrrcular 
and aortic pressures. Results: The aortic valve opens by 2.1*0.5% (Mean&EM) prior to 
e)ection and is related to basal and commiesural expansion during the isovolumic con- 
traction. When the valve opens, aortic pressure is higher than left ventricular pressure 
(gradient: -8.5~t2.6 mmHg). The 3 leaflets do not open at the same time. Although the 
order was consistent for each sheep, no general pattern was found. Aortic valve opening 
is maximal during the first third of ejection. The orifice is clover-shaped because the leaf- 
let area expansion exceeded the commissural area expansion by 16.3+2.0%. It is also a 
cone-shaped cylinder because the leaflet area expansion never surpassed the area 
expansion of the base (-41.5&5%). Aortic valve closure is sharp and started immedl- 
ately after the valve reached maximum opening. When the valve close, the aortic pres- 
sure remains higher than left ventricular pressure (gradrent: -13.2i-1.5 mmHg). 
Conclusions: The aortic valve opening starts prior to ejectron. MaxImum aortic valve 
opening is a cone-shaped cylinder with a clover-shaped orifice. This knowledge of the 
aortic valve dynamics hrghlights the limitations of present day aortic root replacement 
technioues. 
1049-106 Preoperative Plasma Concentration Ratio of Atrial 
Natriuretic Peptide to Brain Natriuretic Peptide (ANP/BNP) 
Is a Biochemical Marker for Predicting the Outcome of the 
Maze Procedure 
Fumrki Yoshihara, Toshio Nishikimr, Yoshikado Sasako, Junjiro Kobayashi. Ken]i 
Minatoya, Ko Bando, Yoshro Kosakai, Takeshi Horio, Shin-ichi Suga, Yoshihiko Ikeda, 
Chikao Yutani, Soichiro Kitamura, Hisayuki Matsuo, Kenji Kangawa. National 
Cardiovascular Center, Suita, Japan, Dokkyo University School of Medicine, Mibu, Japan 
Background: Previous studies demonstrated that patients with persisting atriai fibriila- 
tion after the maze procedure (AF group) had a larger preoperative left atria dimensron 
compared wltii the patients with sinus rhythm after the maze operation (SR group). This 
may be aitributed to the degenerative changes of the atria myocardium in the AF group. 
Because ANP is mainly synthesized in the atrial myocardium, we hypothesized that 
plasma ANP levels might reflect the degenerative changes of the atrial myocardium. 
Methods: The present study was designed to examine whether a preoperative plasma 
ANP or ANP/BNP ratio can predict the outcome of the maze procedure (SR group n=37, 
AF group n=lO). We also evaluated the gene expression of ANP, type I and type Ill col- 
lagen and the collagen volume fraction rn the excised left atria appendages as indices of 
qualitative changes of the atrial myocardrum (SR group n=28, AF group n=5). Results: 
The preoperative plasma ANP level (59.2+/-46.3 vs. 32 7+/-27.5 pg/ml, ~~0.05) and the 
ANPiBNP ratio (0.59+/-0.34 vs. 0.33+/-0.12, ~~0.05) were significantly higher in the SR 
group than those in the AF group. In 23 patients with a preoperative ANPiBNP ratio 
above the median value (>0.47), SR was restored in 22 patients (96%). In contrast, in 10 
patients of the AF group, 9 patients (90%) had a lower ratlo than the median value 
(~0.47). Furthermore, in patients with a left atrial dimension above 65 mm before the 
maze operation (n=8), all 4 patients in the SR group had a higher preoperative ratio than 
the median value, whereas all 4 patients in the AF group had a lower ratio than the 
median value. The gene expressions of ANP, type I and type Ill collagen in the left atria 
appendages were significantly lower in the AF group (-15%, -44%, -44%) than those in 
the SR group. The collagen volume fraction was significantly higher in the AF group than 
that in the SR group (+68%). Conclusion: Our results suggest that the preoperative 
ANPiBNP ratio is a useful biochemical marker for predicting the outcome of the maze 
procedure because the atria degenerative changes may be more advanced in the AF 
group than those rn the SR group, which results in a decrease of ANP secretion from 
their atrial myocardium 
1049-107 Early and Late Results of Minimally Invasive Mitral Valve 
Surgery 
Lawrence H. Cohn, Gregory S. Couper, Sary F Arankr, Margaretta G. Byrne, David H. 
Adams. Brigham and Women’s Hospital, Boston, MA 
Background: Minimally invasive mitral valve surgery has potential advantages in reduc- 
ing trauma, blood transfusions, and cost, whrle yielding results equal to or better than the 
standard open approach. Methods: From 8/1996 to 812000, 333 consecutive patients 
underwent minimally rnvasive mitral valve surgery: 42 mitral valve replacements and 291 
mitral valve repairs. 104 (31%) were functronai class Ill-IV. Patients ages ranged from 17. 
SO (58). There were 145 females and 188 males. Operative and late mortality,reopera- 
tions, and perioperative events were calculated. In addition, length of stay. blood transfu- 
sions, and new atrial fibrillation were determined. Results: The overall operative 
“Ortality was 0.3% (11333); ‘l/42 for mitral valve replacement and O/291 for mitral valve 
repair. 7 patients (2%) were moper&d on for perioperative bleeding. Blood transfusions 
averaged 0.9 ulpt. but 216(65%)required no transfusions. The average length of stay was 
6 days (3-46). Only 461332 survivors went to rehabilitation following surgery. In the 4 year 
follow up penod there have been 12 patients requiring moperations (3.4%): one aortic 
valve replacement, one residual atnal septal defect and lo/291 patients undergoing 
mitral valve repalr required a reoperatlon for failed valvuloplasty. New atrial fibrillation 
occurred in only 601224 patients in normal sinus rhythm (26%). Conclusion: Minimally 
invasive mitral valve operatrons through a lower mini sternotomy can be done safely and 
with low penoperative morbidity and reduced blood usage. Most importantly, minimizing 
the incisional approach to patients with mitral valve disease does not compromise the 
efficacy of mitral valve operations. 
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1113-103 Histopathological Study of Congenital Bicuspid Aortic 
Valves 
Koichi Tamura, Masamichi Ishizaki, Yurchi Sugisaki, Yakashi Saku, Zu-Xi Yu, Victor J. 
Ferrans. National Hearf, Lung and Blood Instifute, N/H, Bethesda, MD, Nippon Medical 
School, Tokyo, Japan 
Background: Many reports have described complications of bicuspid aortic valves 
(BAVs), including aortic stenosis (AS) and regurtitation [AR), infective endocarditis (IE), 
aortic dissectron and other anomalres; however, few studies have been made of the his- 
tology of BAVs. Methods: Gross anatomrc, histologic and immunohistochemical studies 
using an antibody against heparan sulfate proteoglycan (HSPG) were made of 15 BAVs 
resected at the time of aortic valvular replacement. The patients (11 men and 4 women) 
ranged in age from 8 to 79 years (age distribution according to decade of life: lst, n=l; 
2nd, n=2; 3rd, n=Z; 4th, n=l; 5th, n=l; 6th, n=7, and 7th, n=2). An 11 year old boy also 
had a patent ductus arteriosus and a 65 year old woman had a single coronary ostium. 
Two men, 19 and 57 years old, also had annuloaortic ectasia (AAE). A 64 year old 
woman had histologic evidence of IE. Ten patients (3~20 and 7>60 years old) had AS; 3 
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(2 in there 20’s and 1 in his 50’s) had AR, and 2 (both in their SO’s) had combined AS and 
AR. Results: The BAVs in children were remarkably myxomatous and dysplastic, without 
a layered structure of the valvular tissue. BAVs from young adults showed myxomatous 
changes similar to those found in floppy valves, but with a recognizable layered valvular 
structure. BAVs from older patients showed severe calcification with focal myxomatous 
change. The Raphes were composed of irregularly arranged collagen bundles and 
showed mucoid degeneration, even in children. Calcification of the raphes was found in 
young adults but was more severe in older patients. lmmunohistochemical staining for 
HSPG was positive in raphe, myxomatous areas and surrounding areas of calcification. 
Conclusion: BAVs are characterized by variable degrees of valvular dysplasia, with 
abnormalities of extracellular matrix components. Our observations suggest that severe 
dysplastic changes result in AS, whereas less severe dysplastic changes result in AR. 
1113-104 Persistency of Chlamydia Pneumoniae in Degenerative 
Aortic Valve Stenoses Indicated by Heat Shock Protein 60 
Homologues 
Dirk Skowasch, Silvia Lentini, Fiend AndrIb, James A. Likungu, Armin Welz, Berndt 
Liidentz, Gerhard Bauriedel. Heart Center University Bonn, Bonn, Germany 
Background: Nature of degenerative aortic valve stenosis remains uncertain. Recent 
work suggests that valvular degeneration could be caused by inflammatory processes. 
Based on the concept of a chronic persistent Chlamydia pneumoniae infection and of 
variable stressors acting on valvular microecology, the present study sougth to assess 
the presence of the chlamydial, specific heat shock protein (cHSP) 60 and of human (h) 
HSP 60, both known as strong immunogenic agents. 
Methods: Human aortic native (n=21) and prosthetic (n=6) valvular tissue was obtained 
at surgery suffering high-grade stenosis. lmmunhistochemical examination for the pres- 
ence of cHSP 60 and hHSP60 was performed by use of m~n~clonai antibodies that were 
wifhouf cross-reactivity, 
Results: Although expression of both HSP homologues were low, our data demonstrate 
the presence of cHSP and hHSP in a large population of aortic valves, irrespective to 
native or prosthetic origin. Native aortic valve tissue showed immunoreaction specific for 
chronic persistent Chlamydia pneumonias infection in 12 of 21 (46%) valves, whereas 
hHSP 60 expression amounted to 71%. Interestingly, also prosthetic valves revealed 
cHSP signaling in 4 of 6 (67%) and hHSP in 5 of 6 (83%) samples. Expression of both 
HSPs was seen diffusely spread in the tissue with predilection sites at the aortic luminal 
border. inflammatory cells, i.e. CD 68 positwe macrophages, were found colocalized. 
Quantitative evaluation showed immunoreactive cHSP 60 in 2.34?0.82% and hHSP 60 in 
1.54?0.49% of the cells. Both HSPs revealed a strong positive correlation (rz0.859, 
p&01), independent of valv& origin. 
Conclusions: Chlamydia pneumoniae is frequently found in human aortic valves from 
elderly patients subJected to valve repair. Strong correlation of both HSPs indicates to a 
significant stress of the valvular cell population caused by chronic persistent chlamydial 
infections. 
1113-105 Elevated Cell Adhesion Molecule Levels in Patients With 
Chronic Stable Aortic Stenosis 
Gordon E. Pate, Ross T. Murphy, Nitin Ghaisas, Brendan Foley, Peter Crean, Michael J. 
Walsh. Saint &ames’s Hospital, Dublin, lreland 
Background: Aortlc stenosis is a chronic progressive condition of uncertain aetiology. 
Severe symptomatic disease is associated with increased mortality and even mild aortic 
valve disease may not be benign. There is evidence of an inflammatory process as dem- 
onstrated by increased expression of cell adhesion molecules on the valve leaflets and of 
their soluble components in the serum. In particular, serum levels of E selectin, an endot- 
helial adhesion molecule which promotes leucocyte adherence and transmigration, car- 
relate with immunohistochemical staining of aortic valve endothelium post surgical 
excision. Methods: This study examined the relationship between the levels of soluble 
cell adhesion molecules (SCAMS) and the valve gradient by echocardiography or at car- 
diac catheterisation in patients with non-rheumatic aortic stenosis. Stenosis was defined 
according to maximum gradient as mild, moderate or severe (greater than SOmmHg). 
Concomitant coronary artery disease was graded as not significant, mild, moderate or 
severe. Patients with known rheumatic heart disease, infective endocarditis, chronic 
inflammatory conditions or long-term anti-inflammatory or immunosuppressive therapy 
were excluded. Levels of soluble E Selectin, soluble P Selectin, soluble Vascular Cell 
Adhesion Molecule 1 (sVCAM l), and soluble Intercellular Adhesion Molecule 1 (slCAM 
I), were measured by enzyme linked immunosorbent assay. 25 volunteers were used as 
controls. Results: 79 patients (mean age 70 years, 44 male) were assessed. Levels of 
soluble E Selectin were higher in the aortic stenosis group compared with controls 
(43+19 vs 34e7 rig/ml, p=O.O3), as were levels of soluble P Selectin (130~105 vs 75227, 
p=O.O5) and soluble I%AM 1 (287+92 “s 23&35 ngiml, p = 0.005). Levels of sVCAM 1 
did not differ significantly from controls (620&49 vs 55r123 ngiml, p = 0.21). Mean 
serum cholesterol level was 5.0mmol.There was no significant correlation noted between 
gradient and SCAM or cholesterol levels. Conclusions: Patients with chronic stable aor- 
tic stenosis have elevated levels of serum cell adhesion molecules and further study is 
warranted to define their role in the progression of chronic aortic valve disease. 
1113-106 Systemic Hypertension, Hypercholesterolemia, and 
Smoking Are Independent Predictors of Calcific 
Degenerative Aortic Stenosis 
Marcel Pelt&, Faouzi Trojette, Jean-Philippe Lesbre, Christophe Triboullloy. Soulh 
Hospital, Amiens, France 
Background; Histological studies shown that early lesions of degenerative aortic valvu- 
lar stenosis appeared to involve an active process with similarities to atherosclerosis. 
Although some clinical and autopsic studies examined the clinical factors associated with 
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aortic valvular stenosis, the relation between cardiovascular risk factors and severe cal- 
cific degenerative aortic stenosis (CDAS) remains unclear. This prospective study was 
designed to examine the relation between age, sex, hypercholesterolemia, history of 
smoking, systemic hypertension, diabetes mellitus, family of coronary artery disease 
(CAD), and the presence of CDAS. Methods; Between 1994 and 1999, 496 consecutive 
patients considered for surgery who underwent a coronary angiography were included. 
Patients with congenital aortic valve disease ware excluded. Results; Among these 
patlents, 241 had a severe Isolated CDAS (48%) confirmed by surgery (mean age of 69 
+I- 9 years, 157 males) and 255 patients had a valvular regurgitation (mean age of 63 +/- 
11 years, 153 males). By univariate analysis, patients with CDAS were significantly older 
(p=O.OOOl), and had a higher prevalence of hypercholesterolemia (62% vs 39%; 
p=O.OOOl), systemic hypertension (50% vs 31%), and smoking (39% vs 26%; p=O.OOl). 
Total cholesterol (5.69 +I- 1.16 mmolil vs 5.01 +I- 1.25 mmolil; p=O.OOl) and low-density 
lipopotein cholesterol (3.99 +/- 1.19 mmolil vs 3.34 +/- 1.08 mmolil; p=O.O003) were sig- 
nificantly higher in the CDAS group. CAD was most frequent in patients with CDAS 
(p=O.OOOl). After adjustment by age and presence of CAD, systemic hypertension 
(p=O.O03), hypercholesterolemia (p=O.O005), smoking (p=O.O2), age (p=O.OOOl) were 
identified as independent predictors of CDAS. Conclusion; This prospective study dem- 
onstrates that CDAS is not simply a consequence of aging. In addition of age, hypercho- 
lesterolemia, systemic hypertension and smoking are independent predictors of severe 
isolated CDAS. Further prospective studies are needed to examine whether control of 
risk factors slows the progression of degenerative aortic stenosis. 
1113-107 Role of Inflammation in Cardiac Valve Calcification for 
Patients on Long-Term Continuous Ambulatory Peritoneal 
Dialysis (CAPD) 
Angela Y. M. Wang, J Woo, M Wang, P Ho, E Wang, SF Lui, KS Woo, JE Sanderson. 
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of 
Wales Hospital, Hong Kong, Hong Kong 
Background. Valvular calcification (VC) is a serious complication for renal failure 
patients on CAPD. This study aims to determine the prevalence of aortic (AVC) and mitral 
valve calcification (MVC) in CAPD patients and to identify risk factors associated with the 
development of VC. 
Methods. Echocardiograhy was performed in 113 CAPD patients among which 23% had 
MVC and 14% had AVC. Mean serum calcium (Ca), phosphate (PO4), albumin (Alb), 
parathyroid hormone (PTH), alkaline phosphatase, cholesterol, triglyceride, C-reactive 
protein (CRP), fibrinogen as well as mean daily calcium and vitamin D intake and supple- 
mentation during the 12 months preceding echocardiogram was calculated. 
Results were expressed as mean (SD)* or median (interquartile range, IQR)‘*. 
VC (N=35) Non-VC (N=78) P-value 
Age* 60 (10) 55 (12) 0.022 
Duration of CAPD (m)* 47 (26) 44 (28) 0.574 
% with diabetes 38 26 0.184 
Mean Ca (mmol/l)* 2.64 (0.21) 2.59 (0.16) 0.156 
Mean PO4 (mmolil)’ 1.92 (0.49) 1.65 (0.41) 0.004 
Mean Cap04 product* 5.07 (1.42) 4.28 (1.11) 0.002 
Mean serum Alb (g/l)* 26 (4) 29 (3) 0.004 
Mean PTH (pg/l)“* 85 (34, 143) 38 (18,82) 0.001 
CRP (rng/l)*’ 3.1 (0.1, 11.95) 0.1 (0.1,4.4) 0.015 
Fibrinogen (g/l) 6.3 (1.7) 5.7 (1.3) 0.034 
Serum cholesterol (mmol/l)* 5.34 (1.34) 5.68 (1.19) 0.177 
Serum triglyceride (mmol/l)) 2.27 (2.09) 2.16 (2.04) 0.800 
Total daily Ca intake (g/d)” 1.6 (0.7, 2.4) 1.6 (1.1, 2.1) 0.772 
Total daily vitD intake (ug/d)** 5.8 (0.1, 14.0) 2.9 (0.1,11.5) 0.299 
Daily dietary PO4 (mgid)’ 632 (302) 674 (317) 0.547 
Using stepwise logistic regression, most important factors associated with VC include 
patients’ age [OR=1.08, (95% Cl: 1.02, 1.13)], plasma PO4 [O&3.58, (95% Cl: 1.09, 
1 t .72)], PTH [O&l, (95% Cl: 1.0, 1.02)] and serum albumin [OR=0.87, (95% Cl: 0.77, 
0.98)]. A weak but significant correlation was noted between CRP with plasma PO4 
(r=0.234, P=O.O2) and PTH (w0.282, P=O.O05). 
Conclusiqns. VC in CAPD patients is not only associated with high CaP04 product and 
high PTH but also increased inflammation as denoted by more severe hypoalbuminemia, 
higher CRP and fibrinogen. Further study is needed to determine if increased PTH or 
high CaP04 product is responsible for this increased inflammatory response. 
1113-108 Association of C-Reactive Protein Levels but Not Chlamydia 
pneuminae IgG Antibody Titers With Aortic Valve Sclerosis: 
A Population-Based Study 
Yoram Agmon, Bijoy K. Khandheria, Irene Meissner, Jo&an D. Sicks, W. M. O’Fallon, 
David 0. Wiebers, Thomas F. Smith, James M. Steckelberg, James B. Seward, A. J. 
Tajik. Mayo Clinic and Mayo Foundation, Rochester, MN 
Background: Previous studies suggest that Chlamydia pneumoniae (CPn) infection may 
play a role in the pathogenesis of aortic valve sclerosis (AVS). Methods: 380 subjects, a 
sample of the Olmsted County (Minnesota) population (median age: 67 years, range: 51- 
101; 52% men) undetwent transesophageal echocardiography as part of a population- 
based study (SPARC Stroke Prevention: Assessment of Risk in a Community). The 
association between CPn IgG antibody titers, systemic inflammatory markers, and AVS 
(abnormally thick aortic valve leaflets) was examined. Results: AVS was present in 139 
subjects (37%). Low (1:16-1:32), intermediate (1:64-1:128), and high (1:256 or greater) 
titers of CPn IgG antibodies were present in 15%, 37%, and 22% of subjects, respec- 
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tiveiy. CPn antibody titers ware not associated with the presence of AVS (odds ratio [OR] 
1.36 195% confidence interval 0.63-2.96; P=O.43], 0.69 [0.36-l .32, P=O.26]. and 0.63 
[0.30-l .33; P=O.23] for low, intermediate, and hrgh titers, respectively, compared to titers 
<1:16), adjusting for age, sex, and smoking status (never, past, or current smoking). 
Plasma C-reactive protein levels were associated with AVS (OR 1.20 par 2.fold increase 
[i .01-l .43; P=O.O38]), adjusting for age. sex, and smoking, whereas fibrinogen levels 
(OR 1.01 par 10 mg/dL [0.98-1.04; P=O.41]), total leukocytes (OR 0.85 par P-fold 
increase [0.48-l 60: P=O.62]). neutrophils (OR 1.14 par P-fold increase [0.62-2.10; 
P=O.67]), lymphocytes (OR 0.91 par lO’9iL [0.72-1.13; P=O.38]). and monocytes counts 
(OR 1.64 per 10*9/L [0.23-l 1.8: P=O.62]) were not. Conclusions: C-reactive protean lev- 
els are associated with AVS in the general populatron but CPn antibody titers are not. 
These findings suggest that inflammation. but not CPn infection, plays a role in the patho- 
genesis of AVS. 
1113-109 Matrix Metalloproteinase MMP 2 but Not MMP 9 Is Involved 
in Fibrocalcific Aortic Stenosis 
and SV were obtained perioperatrvely from 14 patients on ACEI and 29 control subjects. 
Patients with diabetes, hypercholesterolemia and smoking were excluded. In vitro endot- 
hellurn dependant and independent responses to acetylcholine (ACh) and sodium nitro- 
prusside (SNP) ware assessed in precontracted rings in the presence and absence of 
Bosentan (ETaib receptor antagonist 3uM) and BQ-123 (ETa antagonist 1uM) using the 
organ bath apparatus. Percent maximum relaxation (%Emax) and sensitivity (pEC50) 
ware compared between interventions. Results: ACh cause dose-dependant endothe- 
lium mediated relaxation in ITA and SV; thus response was augmented in vascular seg- 
ments obtained from patients treated with ACEI (p&005). Both specific and mixed ET 
receptor blockade improved ACh-mediated vasorelaxation in the ACEI treated and 
untreated groups (~~0.02). The affects of these antagonists were endothelium specific 
since endothelium independent responses to SNP remained unaltered. Furthermore, the 
beneficial effects ware mediated by ETa receptors since BQ-123 and Bosentan indepen- 
dently and maximally Improved endothelial function in ITA and SV. Conclusion: These 
data uncover for the first time the ability of the ET antagonist to augment the endothelial 
protective actions of ACEI in human bypass conducts. Targeting and improving endothe- 
lial function may prevent perioperative vasospasm and impede graft atherosclerosis. 
dens J. Kaden, Rainer Grobholz. Carolin S. Fischer, Daniela C. Vocke, Carl E. Dempfle, 
Claudia Liebetrau, Christian Vahl, Martin Borggrefe, Peter Gaudron. Department of 
Medicine /I, University of Heidelberg, Maannheim, Germany 
Background: Frbro-calcification of valve leaflets is the main reason for aortic stenosis in 
the elderly. It is characterized by chronic rnflammation and extensive remodeling of the 
extracellular matrix. The role of the gelatin degrading enzymes matrix metalloproteinase 
(MMP) 2 and 9 (Gelatinase A and 8) in this disease has not yet been determined. 
Methods: Human aortic valves with (n=l9) and without (n=4) calcific aortic stenosis 
were obtained at valve replacement or post mortem, respectively. lmmunohistochemistry 
on cryosections, western blot analysis. and gelatin zymography for MMP 2 and MMP 9 
were performed. 
Results: MMP 2 immunoreactivity was shown in fibroblasts and fibrocytes. Staining 
intensrty was significantly higher in stenosed valves by semiquantrtative scoring (1.3+0.1 
versus 0.5+0.0 arbitrary units, p<O.OOl). lmmunostaining for MMP 9 showed lass than 
1% positive cells in ail valves. Western analysis and gelatin zymography showed bands 
at 72 kDa (MMP2) with higher band intensities in s&nosed valves by densitometry No 
bands were identified at 92 kDa (MMPS). 
Conclusion: MMP 2 (Gelatinase A) is constituously expressed rn human aortic valves at 
a low level and upregulated in fibrocalcific aortic Stenosis whereas MMP 9 (Gelatinase B) 
is not expressed at significant levels I” human aortrc valves. These results indicate a 
pathogenetic role of MMP 2 in fibrocalcific aortic valve stenosis. 
815-3 
9:45 a.m. 
Right Ventricular Cardiomyoplasty for the Treatment of 
Severe Right Ventricular Dysfunction: Long-Term Follow-Up 
Guy Fontaine, Juan Carlos Chachques, Pantelis Argyriadis, Jean-LOUIS Hebert, Fabrrce 
Fontaliran, Alain Carpentier. H6pital Jean Rostand, lvrysur Seine, France, H8pital 
Broussais, Paris, France 
A specific technique of right ventricular cardiomyoplasty (RV-CMP) has been developed 
for the treatment of severe right venincular dysfunctron associated or not wrth tricuspid 
regurgitation. Six consecutive patients including 4 males 38 year old (15-63) out of a 
series of 112 cardiomyoplasties had predominant right ventricular dysfunction associated 
with tricuspid regurgitation in 5. Two patients had ischemic heart disease, two RV dyspla- 
sia and congenital anomaly was observed in the 2 remaining patrents. All were in NYHA 
functional class Ill and one in class IV. RV-CMP consists of fixing the latissimus dorsi 
muscle (LDM) flap to the diaphragm. The LDM IS electrostimulated in synchrony with the 
ventricular systole by a special pulse generator. Four patients also had tricuspid valve 
repair and one replacement. One patient was operated wrthout extracorporeal circulation. 
One patient received a rate responsive dual-chamber pacemaker. Hemodynamic param- 
eters were assessed blindly by isotolsic MUGA scan, echocardiography or ultra-fast CT 
scan. Results: All the patients are alive in functional class I, one in II for a follow-up 
period ranging from 6 to 11 years, except one who died of a non-cardiac cause in func- 
tional class II 7 years after surgery. Hemodynamic results recorded at the last follow-up 
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815-l 
9:15 a.m. 
Progression of Atherosclerotic Plaques in Native Coronary 
Arteries Following CABG: Influence of ACE Polymorphysm 
Eduardo Guarda, Ricardo Baera. Cafholic Universify of Chile, Santiago, Chile 
Background: It has been shown that homozygous D/D patients for the ACE polymor- 
phrsm have more incidence of AMI and in-stent restenosis. Herein we explored the posse- 
bility that D/D patrents might have more progression of atherosclerosis than patients 
without the allele D and also studied the influence of such polymorphism upon graft per- 
meability. Methods: We prospectively performed an elective coronary angiogram to 49 
consecutive patients having CABG 1 year after the surgery. Using quantitative angiogra- 
phy we analyzed 101 stenosis in native arteries in these patrents (47 man). ACE poly, 
morphism was studied by PCR. Results: One year graft patency was as follows: LIMA 
98 %, RIMA 1 OO%, Radial 73%, veins 71 %. Reference diameter decreased from 3 r 0.1 
to 1.7 t 1.4 mm (p< 0.0001); minimal iuminal diameter decreased from 1 + 0.5 to 0.5 + 
0.4 mm (p<O.OOi): % stenosis increased from 67 5 15 to 84 r 19% (p<O.OOi). Progres- 
sion of the disease according to genotype was: DD 26%; DI 15%; II 0.40% (p c 0.01). 
Patients DD showed more frequently progression * 20% ( p co.02 vs. genotypes DI or II). 
We found no correlation between genotypes and graft patency, but there was a weak 
negative correlation between plasma cholesterol levels and dtsease progression (I = 
0.33, p’ 005). Conclusion: We observed a significant progression of atherosclerotic 
plaques in native coronary arteries 1 year after CABG. This finding was more frequently 
seen in patients with genotype DID. 
815-2 
9:30 a.m. 
Endothelin Receptor Blockade Potentiates the Endothelial 
Protective Effects of ACE inhibitors in Human Bypass 
Conduits 
Subodh Verma, Satish R. Raj, Fina Lovren, Todd J. Anderson, Andrew Maitland, Aaron 
S. Dumont Universify of Calgary Calgary, AB. Canada 
Background: Endothelin-1 (ET-l) has been implicated in the development of vasospasm 
and graft atherosclerosis. To examine whether ET antagonism augments the endothelial 
protective effects of ACE inhibition, we studied the effects of acute ET receptor blockade 
on endothelial function in Internal thoracic arteries (ITA) and saphenous veins (SV) har- 
vested from patients treated with and without ACEI. Methods: Vascular segments of ITA 
- , ” 1 
RVEF 20% f 9.7 (12-31) 32%tll.3(18-51) 0.013 
LVEF 37% k 12 (26-56) 51% r 14 3 (28-58) 0.02 
RV Dra 42 i 13 (22.60) 32.5 i 9.4 (1844) 0.04 
MPAWP 29.2 + 9.1 (19.401 20.5 + 7.4 (12.301 0.007 
I  I  I  
Legend: RVEF:Right Ventricular Ejection Fraction, Dia: Diameter, MPAWP:Mean Pulmo- 
nary Artery Wedge Pressure. For the patients who had isolated CMP, the LVEF improved 
from 38 to 58%. Conclusion: This study suggests that with no operative mortality and a 
long-term follow-up, a specific form of RV-CMP generally associated to tricuspid surgery, 
is an effective treatment of predominant severe right ventricular dysfunction. 
815-4 
lo:oo a.m. 
Leaflet Separation and lnterleaflet Shearing During Acute 
lschemic Mitral Regurgitation 
David T. M. Lai, Tomasz A. Timek, Paul Dagum, Sidney Lo, Truls Myrmel, Frederick A. 
Tibayan, David Liang, George T. Daughters, II, Neil 6. Ingels, Jr., D. 6. Miller. Stanford 
Universfty School of Medicine, Stanford, CA, Research Institute of the Palo Alto Medical 
Foundation, Palo Alto. CA 
Background: To determine the 3.dimensional (3-D) perturbations of the mitral leaflet 
geometry that could lead to mitral regurgitation during acute left ventricular (LV) 
ischemia, the 3-D positions of the posterior mitral leaflet edge were measured using a 
new reference system (relative to the anterior mitral leaflet edge) in sheep. 
Methods: Radiopaque markers A, B & C [Figure) were sutured to the medial, middle and 
lateral edges, respectively, of the anterior mitral leaflet, and D, E & F to adjacent sites on 
the posterior mitral leaflet edge in 6 sheep. Eight additional markers were placed around 
the mitral annulus. Following 8 + 2 days recovery, 3-D marker coordinates were obtained 
by simultaneous biplane videofiuoroscopy at 60 Hz in sedated closed-chest conditions 
before and during balloon occlusion of the circumflex coronary artery to create postero- 
lateral LV ischemia sufficient to produce mitral regurgitation (MR) as verified by echocar- 
diography. 
Results: Projections of leaflet marker positions are shown on the best-fit annular plane 
at end-systole (Figure). Markers A, B & C are depicted in the same locations before and 
during ischemia. Posterior mitral leaflet marker displacements (mm, ~~0.05) relative to 
each matching marker on the anterior mitral leaflet are depicted before (open circles) and 
during (filled circles) ischemia. 
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Conclusion: During acute LV ischemia, systolic leaflet separation occurred with dls- 
placement of all 3 posterior mitral leaflet sites away from the anterior mitral leaflet 
towards the posterior mitral annulus. Unexpectedly however, the middle and lateral edges 
of the posterior mitral leaflet sheared relative to the anterior mitral leaflet, moving towards 
the posterior commissure. This new aspect of perturbed leaflet geometry needs to be 
considered in surgical attempts to repair ischemic MR. 
IO:15 a.m. 
815-5 Chronic Therapy With the Acorn Cardiac Support Device 
(CSD) Attenuates Cardiomyocyte Apoptosis in Dogs With 
Heart Failure 
Ramesh C. Gupta, Victor G. Sharov, Sudhish Mishra, AnastassiaTodor, Ham N. Sabbah. 
Henry Ford Health System, Detroit, MI 
BackgrounckChronic therapy with Acorn Cardiac Support Device (CSD),a preformed 
polyester mesh surgically placed around the ventricles, prevents progressive LV dilation 
and improves LV ejeclion fraction in dogs with chronic heart failure (HF). In the present 
study, we examined whether chronic therapy with the CSD influences cardiomyocyte 
apoptosis in dogs with HF produced by intracoronary microembolizations. 
Methods: The study consisted of 12 dogs with HF; 6 dogs received a CSD and 6 served 
as concurrent controls. All dogs were followed for 3 months prior to sacrifice. LV tissue 
from 6 normal dogs was used for cornpar~son. The incidence of cardiomyocyte apoptosis 
was determined in freshly frozen sections based on nuclear DNA fragmentation using the 
TUNEL method. Cardiomyocyte apoptosis was examined in regions bordering old inf- 
arcts (Border), in regions remote from any scar tissue (Remote), and in all regions com- 
bined (Overall). Within each region, apoptosis was quantified as TUNEL positive 
cardiomyocytes per 1000. LV homogenate from freshly frozen LV tissue was also used to 
examine the expression of the apoptosis-associated proteins Bcl-2 and Bax Bands from 
Western blots were quantified in densitometric units. 
Results: The results are in the table. 
JACC February 2001 
thromboembolic events after LAA ligation suggests that LAA ligation does not provide 
adequate protection alone against thromboembolism in the absence of adequate antico- 
agulation. 
1212 p.m. 
1005-202 Women Have Higher Operative Mortality After Coronary 
Artery Bypass Surgery: Why? 
Raymond H. Chen, Farzan Filsouf!, Samuel 2. Goldhaber, John G. Byrne, Lishan Aklog, 
David H. Adams. Brigham & Women’s Hospital, Bosion, MA 
Background: To clarify whether gender alone or associated preoperative risk factors 
contribute to higher mortality in women after coronary bypass surgery. Methods: 
Between 1193 and 12198 4215 patients (median age 66 years, range 27-94 years, 28 % 
female) underwent primary CABG at our Institution. Potential confounders of the relation- 
ship between gender and mortality were examined. Multivariable logistic regression was 
used to evaluate the risk of operative death related to gender after controlling for potential 
confounders. With a 2% mortality rate, our sample has a power of 0.92 to show a dou- 
bling of risk for females. Results: The overall operative mortality was 2% (3.5% in 
females; 1.4% in males) [p<_O.O005]. Women were more likely to be older and smaller, 
with diabetes mellitus, renal failure, hypertensive, stroke, COPD, recent MI, high choles- 
terol, cardiomegaly, wowa functional class and urgent status, while men were more likely 
to have lower EF, smoking history, 3.vessel disease, and unstable angina. Univariable 
odds ratio for females for operative death was 2.7 (95% Cl: 1.7,4.1; p<O.OOOS). When 
potential confounders and gender were entered into the multivariable model, female gen- 
der was not a significant predictor of operative mortality following CABG (OR 1.3, 95% 
Cl: 0.76-2.4; p&31). In analyses stratified by gender, stroke (OR 2.6, 95% Cl: 1.2-5.6; 
p=O.Ol), urgency (OR 2.3, 95% Cl: 1.2-4.6; p=O.Ol), and cardiomegaly (OR 2.3, 95% Cl: 
1 .l-4.9; p=O.O4) were predictive of operative mortality in women, while EF<30% (OR 3.6, 
95% Cl: 1.8-7.5; p=O.OOl), hypertension (OR 2.8, 95% Cl: 1.2-6.4; p=O.O2), urgency (OR 
2.6, 95% Cl: 1.3-5.0; p=O.O06), mitral insufficiency (OR 2.2, 95% Cl: 1.1-4.3; p=O.O3), 
age 3 75 years (OR 2.1, 95% Cl: 1 .l-4.3; peO.03) predicted mortality in men. Conclu- 
sions: Gender does not piedict operative mortality following primary CABG. Instead, 
gender-based mortality differences reflect preoperative clinical status. 
12:24 p.m. 
1005-203 Determinants of Favorable Outcome Following 
Extracorporeal Membrane Oxygenation for Cardiac Failure 
in 128 Adults: A Single Center Experience 
Ko Bando, Yoshikado Sasako, Shunichi Miyazaki, Junjiro Kobayashi, Hiroaki Konishl, 
Toshihiko Sate, Takeshi Aiba, Kazuo Niwaya, Toshikatsu Yagihara, Osamu Tagusari, 
Soichiro Kitamura. National Cardiovascular Center, Osaka, Japan 
Background: The study was performed to define the survival and optimal indication for 
ECMO in a diverse population of patients (pts). Methods: One hundred twenty-eight 
adult pts (52218 years) were placed on ECMO support between 1991-2001. Indications 
for cardiac support included emergency cardiac resustitation (30), high-risk cardiology 
intervention (26), myocardial infarction (24), postcardiotomy (22), decompensated heart 
failure for acute myocarditis (14), DCM (7) and others (5). Follow-up was 100% complete 
(mean 67.5~45.7 mos). Survival and morbidity was evaluated multivariately by Cox 
regression. A stepwise logistic regression analysis was used to identify predictors of 
early and late survival after ECMO. Results: Forty-seven pts were weaned. Ten pts were 
bridged to LVAS, of those 5 pts were weaned from LVAS and survived, 1 pt resulted in the 
second successful heart transplant in Japan and remaining 4 pts died on LVAS support. 
Seventy-one pts died on ECMO. Early mortality was associated with irreversible myocar- 
dial damage in 38, severe neurological deficit in 28, and multi-system organ failure in 24 
or combination of these complications. Overall 40 pts (31%) were discharged. By logistic 
regression, early survival was predicted by younger age (odds ratio, OR:2.01), pts with- 
out CPR before ECMO support (OR:3.53), and pts with heart failure for acute myocarditis 
or DCM (OR:4.22). Only three late deaths occurred after discharge. A hazard function 
analysis for risk of death revealed an extremely high risk phase within 4 days after the ini- 
tiation of ECMO followed by a period of constant low risk. Conclusions: ECMO can be 
used in diverse indications for cardiac collapse. Although overall mortality remains high, 
the use of ECMO results in excellent late survival among pts with younger age, pts with- 
out CPR before ECMO and pts with heart failure for acute myocarditisiDCM. 
12:36 pm. 
1005-204 Pericardiectomy for Chronic Relapsing Pericarditis 
Kevin L. Greason, Gordon K. Danielson, Jae K. Oh, Rick A. Nishim& Mayo Clinic, 
Rochester, MN 
Background: Chronic relapsing pericarditis may render patients disabled and steroid- 
dependent. The role of surgical treatment is still controversial. 
Methods: We retrospectively reviewed the records of all patients who had undergone a 
radical pericardiectomy for chronic relapsing pericarditis on one surgical service between 
1975 and September, 2000. 
Results: Ages of the 41 patients (22 men, 19 women) ranged from 15 to 73 years 
(median, 36). Symptoms included chest pain (n=41, lOO%), fever (n=21, 51%), and 
fatigue @=I& 44%). Duration of symptoms ranged from 2 to 228 months (median, 19). 
All patients were on medications and the number taken per patient ranged from 1 to 24 
(median, 3). Thirty-six patients (88%) were on steroids of which 25 (69%) reported ste- 
roid-related complications including diabetes, obesity, vision changes, hypertension, frac- 
tures, avascular necrosis of the hip, gastrointestinal bleeding, and colon perforation. 
Etiologies were idiopathic (n=34), postoperative (n=3), post-viral (n=Z), endocardial 
pacemaker lead (n=l), and iuberculous (n=l). Exposure was via median sternotomy 
(n=27, 66%) or left anterior thoracotomy (n=14, 34%). Operative findings corroborated 
the diagnosis of pericarditis in all patients. Five patients (12%) had early constriction 
NORMAL HF HF+CSD, 
TUNEL c/1000 Remote 0 0.34i 0.12” 0.11 t 0.05 
TUNEL+/iOOO Border 0 5.20 i-0.12A 0.28 k 0.09* 
TUNEL +/lo00 Overall 0 2.78+ 0.40” 0.20 + 0.05* 
Bcl-2 1.06 i 0.09 0.94 f 0.12 1.08 + 0.07 
Bax 1.63iO.18 2.60 r 0.15” 1.47+_0.14* 
“=P<O.O5 vs. NORMAL; *=P<O.O5 vs. HF 
In CSD-treated dogs, the incidence of cardiomyocyte apoptosis was significanly lower 
than in untreated HF dogs. CSD-treated dogs showed no changes in Bcl-2, an anti-apop- 
tosis protein but showed significant reduction in the expression of Bax, a pro-apoptosis 
protein. The resulting increase in the ratio Bcl-PiBax in CSD-treated dogs favors cell sur- 
vival. 
Conclusions: In dogs with HF, chronic therapy with the Acorn CSD attenuates cardiomy- 
ocyte apoptosie. This finding is consistent with the reverse cellular remodeling that 
occurs with this form of therapy for chronic HF 
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1005-201 The Effect of Left Atrial Appendage Ligation During Valvular 
Surgery on Thromboembolic Events 
Nour M. Juratli, Mina K. Chung, Delos M. Cosgrove, Bruce W. Lytle, Patrick J. Tchou, 
Bruce L. Wilkoff Walid Saliba, Fred J. Jaeger, Robert A. Schweikert, Luther T. Clark, 
Mark J. Niebauer, Andrea Natale. Cleveland Clinic Foundation, Cleveland, OH 
Background: The left atrial appendage (LAA) is the most common cardiac site for throm- 
bus formation in atrial fibrillation (AF), and adequate anticoagulation with warfarin is the 
therapy of choice to reduce the risk of thromboembolic events (TE) in high risk patients. 
LAA ligation has been suggested as an alternative therapy to warlarin, but its effective- 
ness in the prevention of TE has not been established. Methods: Between 5193 and 1 li 
98, 146 patients underwent LAA ligation during valvular surgery. Mitral valve procedures 
were performed in 137 cases (93.8%). The valve was replaced with a bioprosthetic valve 
in 44 pts (30%) or mechanical valve in 36 pts (24.7%) and repaired in 62 pts (42.5%). 
Previous history of TE was present in 24 pts (16.4%), and atrial fibrillation was present in 
106 pts (72.6%), including 22 pts with only postoperative atrial fibrillation. The mean age 
was 63.9i12.5 yrs and the mean LVEF was 44.6t13.3%. Left atrial size was 5.68i1.15 
cm. Warfarin was prescribed to 88 (60.3%) pts prior to discharge home. Qperation 
reports, a cardiothoracic surgery database, and telephone contacts were used to assess 
the occurrence of TE after LAA ligation. Results: Follow up was achieved in 120 pts 
(82.2%). TE occurred in 15 pts (12.5%) over a follow up period of 1192i583 days. Two of 
15 pts had mechanical valve replacement (one aortic and one mitral), 6 had mitral valve 
repair, and 7 had tissue mitral valve replacement. Stroke or transient ischemic attack 
(TIA) occurred in 13 pts, and 2 pts had fatal embolic accidents to the lefl main trunk and 
the mesenteric artery. No warfarin therapy or subtherapeutic anticoagulation was present 
in 14 pts during TE. One patient who suffered recurrent TIA despite adequate anticoagu- 
l&ion was found to have severe carotid disease. Conclusion: The high incidence of 
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Concomitant procedures included atria septal defect closure, coronary revasculariration, 
and mitral valve repair. There was no early or late mortality; morbidity included wound 
complication (n=2) and reoperation for bleeding (n=l). Follow-up ranged from 1 to 201 
months (median, 17). Twenty-five patients (61%) had follow-up of one year or more; all 
25 reported symptomatic Improvement and 23 (92%) were steroid-free at follow-up. 
Conclusion: Radical pencardiectomy provides significant symptomatic relief for patients 
with chronic relapsing pericarditis and should be considered a therapeutic alternative to 
steroid dependency. 
1:12 pm. 
1005-207 Results of Mitral Valve Repair in Patients With Low Ejection 
Fractions 
Gerald M. Lawrie, Nan R. Earle, Elizabeth A. Earle. The f&thodist ffospita, Houston, 
JX, Baylor College of Medicine, Houston, TX 
12:48 p.m. 
1005-205 Aortic Valve Replacement After Previous Cardiac Surgery: 
Clinical and Hemodynamic Predictors of Progression 
S&fan R. Jibodh. Thomas A. Hennebry, Peter S. Greene, William A. Baumgartner, J M. 
Redmond. Johns Hopkins Medical Institutions, Baltimore, MD 
Background. it is unclear whether patients with early aortic valve (AV) disease benefit 
from aortic valve replacement (AVR) at the time of AV-unrelated cardiac surgery. We 
studied patients who underwent AVR after previous cardiac surgery to identify factors 
influencing the interval to moperation. Methods. We identified 50 consecutive patients 
from the institutional database (27 male, 23 female, age 56 * 12 years at initial surgery) 
who underwent AVR + other procedure after previous cardiac surgery. Patients with 
endocarditis or prior AV surgery ware excluded. Cox regression analysis was limiied to 
clinical and catheterization variables with an established role in aortic sclerosis and ath- 
erosclerosis. Results. The mean interval to reoperation was 7.8 I 3.5 years with 11 
patients retirrning in 5 years or less. At Initial operation, 32 patients showed signs of early 
AV disease; 29 had the classic murmur and 13 had an AV gradient (mean 12.8 it 8.8 mm 
Hg). Factors affecting progression are tabulated below. Gender, history of hypertension, 
diabetes or hypercholesteroiemia and ejectiw fraction were not significant determinants 
of progression. Conclusions. The presence of an AV gradient and Increased pulse pres- 
sure, left ventricular systolic pressure, BMI or age were independently associated with 
more rapid progression to AVR. These criteria may help identify those patients most likely 
to benefit from AVR at the time of initial surgery. 
Background: There is limited data regarding the outcome of mitral valve repair (MVRep) 
in patients with low (<35%) lefl ventricular ejection fractions (LEF). 
Methods: From a consecutive series of 304 patients (pts) having MI/Rep between 1984 
and 2000, we reviewed the course of 33 patients with LEF, age (62.1_t12.86), 63.3% 
male with a mean EF of 30.254.2 vs. that of 271 Good EF pts (GEF) age 62.6+14.68, 
48% male (p=NS), mean EF 57.9r10.4. LEF pts were more symptomatic: NYHA class 
was Ill/IV in 72.7% of LEF pts vs. 59.4% for GEF pts. LEF pts had more ishemic heart 
disease: 30.3% vs. 8.1% in GEF (p=O.O036). Mitral valve surgery was more emergent in 
12.1% of LEF pts vs. 3.3% of GEF pts. Anterior leaflet repair was more common in LEF 
pts, 27.3% vs. 17.0%, p=O.O003. Annuloplasty only was performed in 51.5% of LEF pts 
vs. 23.2% of GEF pts (p=O.O032). Coronary bypass was done as a concomitant proce- 
dure in 42.4% LEF pts vs. 21.4% GEF pts. Aortic cross-clamp times were similar, 70.0 
minutes vs. 61.3 minutes (p=NS); but cardiopulmonary bypass times were longer in LEF, 
99.5 “s 80.8, p=O.O033. 
Results: Perioperative mortality (30 day) was 9.1% (3/33) for LEF and 2.2% (61265) for 
the GEF p=O.O278. Late survival (10 yrs) was 33.0% for LEF vs. 60.2% for GEF. Postop 
NYHA class was l/II for 78.8% LEF vs. 77.8% GEE 
Conclusion: Pts with LEF requiring MVRep were more symptomatic and had more com- 
plex pathology preop and required more extensive surgery and more emergency proce- 
dures. Despite this, relief of symptoms in survivors was equally as good as in GEF pts. 
MVRep surgery pts with LEF in the ranges in this study is feasible and produces worth- 
while clinical benefits. The largest differences in survival were observed in the periopera- 
tive period and the first six months after discharge. These findings suggest that improved 
management in this early phase may be able to favorably alter the long term survival of 
pts with LEE 
Factors Affecting Progression to Aortic Valve Replacement 
Hazard Ratio 95% Cl Adjusted For: 
Age 1 .19 (per 5 year increase) 1 .OO - 1.42 Rheumatic Fever 
BMI 1 .11 (per kg/m*) 1.02-1.19 Diabetes Mellitus 
Pulse Pressure 1.48 (per 10 mm Hg) 1.07 - 2.05 Age, Hypertension 
LV Systolic Pressure 1.21 (per 10 mm Hg) 1.06-1.39 Hypertension 
Any AV Gradient 2.67 1.23 5.83 
I:24 p.m. 
1005208 Prevention of Post Cardiac Surgery Atrial Fibrillation in a 
Community Hospital Setting Using a Post Operative Two- 
Tiered Pharmacologic Protocol 
John Mandrola, Sharon Fiuhl, JoAnn Brooks-Brunn. Cardiovascular Associates PSC, 
Louisville, KI: Baptist Hospital East, Louisville, KY 
Background: Atrial fibrillation (AF) remains a significant co-morbidity following cardiac 
surgery. A two-tiered AF protocol based on pre-operative left ventricular ejection fraction 
(LVEF) was implemenied in a community hospital setting with numerous cardiology 
groups. 
Methods: Patients with LVEFz35% received a combination of propafenone 150mg q 81 
metoprolol 25mg q 12 beginning as early post-operatively as tolerated. Patients with 
LVEF<35% received amiodarone 400mg q 6 beglnning immediately post-operatively. Ini- 
tially, non-protocol patients received no membrane active antiarrhythmic agents. 
Results: 185 consecutive pabents undergoing cardiac surgery were evaluated: 114 were 
on protocol and 71 were not on protocol. Baseline characteristics of protocol and non- 
protocol patients including sex, age, hypertension, diabetes, pre-op AF, LVEF and type of 
cardiac surgery were similar. 13/114 (11.4%) protocol patients had sustained AF 
(>30min) as compared to 23I71 (32.4%) non-protocol p&en&. (p=O.OOl). Mean AF dura- 
tion in protocol patients was 1 day vs. 3.3 days in non-protocol patients. (p=O.Oi 5). Mean 
length of stay for protocol patients was 8.04+6.5 days (median 6.0) versus non-protocol 
8.73+4.92 days (median 7.0). lOn1 (14%) non-protocol patients and 31114 (3%) protocol 
patients had non-sustained ventricular tachycardia (NSVT). (p=O.O06). Electrophysio- 
logic (EP) studies were performed in 7171 non-protocol patients and 11114 on protocol 
patients. (p=O.O06). One patient in each group had inducible VT and underwent defibrilla- 
tor implant. 1 proiocol patient had propafenone discontinued secondary to GI symptoms 
and 2 protocol patients had propafenone changed to amiodarone due to refractory AF 
No serious adverse events were attributed to the AF protocol drugs. 
Conclusions: A simple (post-operative) AF protocol using either a propafenone/meto- 
prolol combination or amiodarone significantly reduced both the incidence of sustained 
AF and the mean duration of AF. Although not statistically significant, a trend toward 
reduction of length of stay was observed. AF protocol patients had less NSVT and fewer 
EP studies. The AF protocol was safe and well tolerated. 
1 :oo p.m. 
1005-206 Long-Term Survival Following Mitral Valve Replacement 
and Coronary Artery Bypass Grafting: Impact of an 
lschemic Versus a Degenerative Etiology of Mitral 
Regurgitation 
Peter S. Dahlberg, Thomas A. Orszulak, Charles J. Mullany, Richard C. Daly, Maurice 
Enriquez-Sarano, Hartzell V. Schaff. Mayo Clinic, Rochester, MN 
Background: Survival following combined mitral valve replacement and coronary artery 
bypass grafting may depend on the cause of mitral regurgitation. The purpose of this 
study was to determine the impact of an ischemic etiology of mitral regurgitation on 
patient survival. 
Methods: We retrospectively reviewed 34 consecutive patients undergoing mitral valve 
replacement and coronary artery bypass grafting for ischemic or degenerative mitral 
regurgiiation from 1987 to 1993. Group comparisons were performed with the t or X2 
test. Survival was estimated by use of the Kaplan-M&r method. Multivariate analysis 
was performed using the proportional hazards technique. 
Results: The cause of mitral regurgitation was ischemic in 19 (55%) and degenerative in 
15 (44%). Compared to those with degenerative mitral regurgitation, patients with 
ischemic mitral regurgitation were more likely to have unstable angina, an acute infarc- 
tion, 3-vessel coronary disease, and poor lefl ventricular function. They were also more 
likely to undergo an emergency operation (47% vs 0%) and require postoperative balloon 
support (47%~~ 0%) (Table). Despite these risk factors there were no significant differ- 
ences in 30.day mortality or 5 year and 10 year survival rates between patient groups 
(Fiaure). Multivariate analvsis suaaested that onlv weoperative left ventricular eiection 
fra&on.c 35% significantly~affectedsurwal. 
,. 
lschemic Degenerative Survival 
Age 
NYHA U 
Unstable Angina 
Acute MI 
EF <35% 
3 Vessel CAD 
Emergency 
X-clamp 
Bypass 
30 dav mortalitv 
66 68 NS 
89% 100% NS 
37%* 7% NS 
52%’ 0% 0.48 
27% 6% 0.005 
79%’ 50% NS 
47%* 0% 0.17 
105 105 NS 
170 161 NS 
21% 14% 
*p<O.O5 vs Degenerative X2 
Conclusions: lschemic etiology of mitral regurgitation is not an independent risk factor 
for death following mitral V&e replacement and coronary artery bypass grafting. Sur- 
vival is determmed by the preoperative left ventricular ejection fraction. 
I:36 p.m. 
1005-209 Telemedicine for Cardiac Surgery Candidates: The Initial 
Swiss Experience 
August0 F. Gallino, Andrea Menafoglio, Sr., Luca Calanca, Agostino Faggiotto, Luigi 
Caoduro, Ludwig “on Segesser. Division of Cardiology: Ospedale San Giovanni, 
Bellinzona, Switzerland, Division of Cardiac Surgery University Hospital, Lausanne, 
Switzerland 
Background: Cardiac Surgery is generally well or over-represented in many western 
countries. Yet, there are few areas in which cardiac surgery is not easily accessible. 
Since the southern part of Swtzerland relies on cardiac centers that are 200-300km 
apart, we started (6/97) a project of t&medicine. Herewith, we report our first 18 months 
experience as well as the blinded comparison of the diagnoses made by telemedicine 
and by the direct scrutiny of coronary angiograms. Methods: Coronary angiography was 
performed at the distant hospital by a team wth expertise in invasive and interventional 
cardiology. T&transmission of the images of recent recordings was petformed using 3 
ISDN lines (corresponding to 6 channels transmitting at 64 Kbiffsec. each). A total of 98 
cases were reviewed: 86 candidates of AC-coronary bypass, 7 with valvular and 4 with 
congenital heart disease. Results: Blinded comparison of distant and direct scrutiny of 
480A ABSTRACTS - Valvular Heart Disease 
angiograms in the assessment of CAD in l-2-3 vessel disease was good (r=O,87, 
p<O,Ol). In 89 cases (91%) correct diagnosis and surgical approach could be established 
by distant transmission. In 6 cases (9%, all AC-bypass patients) definite diagnosis and 
treatment was feasible only by direct scrutiny of the original angiograms. A total of 5 criti- 
cally il l patients were referred urgently to the surgical care centers based on correct dis- 
tant diagnosis. Conclusions: Initial experience using non sofisticaied t&medical 
transmission of angiograms of cardiac surgery candidates seems to be a promismg 
improvement in the management of cardiac patients that are distant from specialized 
heart surgery centers. 
I:48 pm. 
1005-210 The Effects of Mitral Valve Replacement With or Without 
Preservation of Subvalvular Apparatus on Postoperative 
Left Ventricular Function 
Xianhong Shu, C&hen Pan, Xuedong Shen, Ang Yu, Guoqian Huang. Zhongshan 
Hospital of Fudan University Medical Center, Shanghai, PeopleS Republic of China, 
Shanghai institute of Cardiovascular Diseases, Shanghai, People’s Republic of China 
Objectives: To study the effects of mitral valve replacement (MVR) with or without pres- 
ervation of subvalvular apparatus on left ventricular function. Materials and Methods: 
Thirty patients with chronic mitral regurgitation were classified into three groups. Twelve 
p&n% underwent conventional mitral valve replacement (Group A), 10 patients had 
MVR with preservation of posterior chordae tendineae only (Group B), and 8 patients 
had MVR with preservation of both anterior and posterior chord%? tendineae (Group C). 
HP SONOS 2500 imaging system with automated border detection (ABD) technique was 
used to evaluate I& ventricular end-diastolic volume index (EDVI), end-systolic volume 
index (ES/I), ejection fraction (EF), peak ejection rate (PER), peak fraction rate (PFR) 
and time of peak fraction rate (TPFR) before and three months after surgery. Results: (1) 
There were no significant difference of HR, BP or all ABD parameters among three 
groups before surgery (P>O.O5). (‘2) Three months after surgery, EDVI was significantly 
greater in Group A (PcO.O5), and was significantly reduced in both Group B and C 
(PcO.05). ESVI was not changed in Group A, and decreased significantly in Group B and 
C (P<O.O5). PER in Group A and B were not significantly different, and increased signifi- 
cantly in Group C (P<O.O5). EF was improved in all the three groups after surgery, and 
EF in Group C increased the most among the three groups (P<O.O5). (3) No significant 
difference of PFR or TPFR was found in Group A or Group B compared to those before 
surgery. However, PFR was greater and TPFR was shorter in Group C. Conclusion: 
Conventional MVR may do harm to left ventricular systolic and diastolic function. MVR 
with preservation of both anterior and posterior chordae tendineae has more beneficial 
effect on maintaining or improving postoperative left ventricular systolic and diastolic 
function compared to MVR with preservation of posterior chordae tendineae only. 
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merit of the leaflets in rheumatic fever with resultant leaflet reiraction causes increased 
tension on the chordae, a reduction in the interchordal angle, and a consequent coapta- 
tion defect. 
1115-104 Mechanistic Insights Into Three-Dimensional 
Displacements of the Posterior Mitral Leaflet Relative to the 
Anterior Mitral Leaflet in Dilated Cardiomyopathy 
David T. M. Lai, Paul Dagum, Tomasz A. Timek, Frederick A. Tihayan, David Liang, 
George T. Daughters, II, Neil 8. Ingels, Jr., D C. Miller. Stanford University School of 
Medicine, Stanford, CA, Research lnsdtute of the Palo Alto Medical Foundation, Palo 
Alto, CA 
Background: To define the exact perturbations of mitral valvular geometry that could 
lead to mitral regurgitation (MR) in dilated cardiomyopathy (DCM), the three-dimensional 
(3-D) positions of the posterior leaflet, papillary tips and posterior annulus were mea- 
sured using a new reference system (relative to the anterior mitral leaflet edge) in an 
ovine model of tachycardia-induced cardiomyopathy. 
Methods: Radiopaque marker A (Figure) was sutured to the midline anterior mitral leaf- 
let, B to an adjacent site on the posterior mitral leaflet edge, C to the anterior papillary tip, 
D to the posterior papillary tip, and E, F & G to the posterior annulus in 4 sheep. Follow- 
ing 8 + 2 days recovery, 3-D marker coordinates were obtained using biplane videofluo- 
roscopy at 60 Hz and rapid pacing was initiated. After development of DCM with mild- 
moderate MR, 3-D marker coordinates were compared with control values at end-sys- 
tale. 
Results: The leaflet, papillary tips and posterior annular markers are projected on a 
best-fit annular plane at end-systole in the Figure. Mirker A is depicted in the same loca- 
tion before and following the development of DCM. Posterior mitral leaflet, papillary tips 
and posterior annular displacements (mm, ~~0.05) relative to marker A are shown before 
(open circles) and following (filled circles) the development of DCM. 
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1115-l 03 Morphology of the Rheumatic Mitral Regurgitant Valve by 
Three-Dimensional Echocardiography 
Selwyn P Wong, Renelle A. French, Edward L. Bolson, Malcolm E. Legget, Florence H. 
Sheehan. University of Washington, Seattle, WA, Green Lane Hospital, Auckland, Mew 
Zealand 
Background: Rheumatic fever remains a significant worldwide cause of mitral regurgita- 
tion (MR). Detailed quantitative morphology of the valve apparatus in this disease is not 
well described but would aid surgical repair. In this study the increased quantitative infor- 
mation from three-dimensional (30) echocardiography was used to describe the valve. 
Methods: Eight normal subjects and 16 patients (mean age 29+12 years) with mild 
(N=7) or moderate to severe (N=9) rheumatic MR underwent 30 echo using freehand 
transthoracic scanning. LV borders, mitral chordae, papillary muscles and annulus were 
traced at end-diastole (ED) and end-systole (ES). LV surfaces and the mitral annulus 
were reconstructed in 30. Regional LV function was assessed using myocardial thicken- 
ing. Alignment of ED endocardial surfaces to a reference normal surface was used to 
assess regional LV shape. Results: Compared to normals, the patients with MR had 
more spherical LVs (spheric@ index 0.47 v 0.36, p=O.Oi). The septum was less 
expanded than the opposite LV walls, in which the expansion from the reference normal 
LV shape measured 9+8mm. LV volumes and ejection fraction did not differ from normals 
and function in the regions of papillary muscle attachment was not reduced. The mitral 
annulus was increased in 3D length and area (ED 11.5 v S.lcmz, p=O.O3; ES 11.0 v 
8.0cm2, p=O.O3). These annulus parameters correlated with LVED volume (ED area 
R=0.66, p<O.OOl), but not with LV spheric@. Compared to normals, the rheumatic annu- 
Ius did not differ in height, eccentricity or beat-to-beat deformity. Chordal and papillary 
muscle lengths were not reduced. The angle between the anterior and posterior chordae 
was more acute in MR (13” v 25”, p=O.O4). Conclusion: Mitral apparatus morphologic 
alterations in rheumatic retiurgitant disease are an increased annular area and length, 
and a decreased angle between the chord%. The narrowed interchordal angle is oppo- 
site to the widening seen in MR of dilated cardiomyopathy. We hypothesize that involve- 
Conclusion: In this model of experimental dilated cardiomyopathy, posterior displace- 
ment of the annulus was the predominant perturb&ion that correlated with systolic leaflet 
separation, i.e., an increase in A-B distance. There was no correlation between the direc- 
tion of papillary tip displacement and systolic leaflet displacement in dilated cardiomyop- 
athy. These novel pathophysiological findings may be applicable io surgical repair of MR 
in patients with dilated cardiomyopathy. 
1115-105 Ablation Of Mitral Myocarclial Muscle Effect on Annular and 
Leaflet Dynamics in the Context Of Mitral Repair 
Tomasz A. Timek, David T. Lai, David Liang, Gerald Berry, Frederick A. Tibayan, Paul 
Dagum, George T. Daughters, Neil 8. Ingels, Jr., D C. Miller. Stanford University, 
Stanford, CA, Research Institute of the Palo Alto Medical Foundation, Palo A/to, CA 
Background: Ovine mitral annular (MA) area reduction occurs predominantly prior to 
ventricular systoie, suggesting an atrial influence on MA dynamics. We used the myocar- 
dial marker method to investigate MA and leaflet 3-D dynamics after circumferential phe- 
nol ablation of the annular and anterior mitral leaflet (AML) muscle. 
Methods: Radiopaque markers were sutured to the LV, MA, and central meridian of both 
mitral leaflets in 18 sheep. Eight sheep underwent no further treatment (Control); in the 
remaining 10 sheep, phenol was applied circumferentially to the atrial surface of the 
mitral annulus and the muscle fibers of the AML. After 7~10 days, the animals were stud- 
ied with biplane videofluoroscopy to obtain marker coordinates for computation of precise 
3-D mitral annular area (MAA), leaflet shape, and LV volume. Maximal MAA was calcu- 
lated from 8 annular markers; MAA reduction (MAA-red) during the cardiac cycle was 
determined from maximal to minimal value. Pre-systolic MAA reduction was calculated 
as percent of total reduction occurring prior to end-diastole. Mitral valve closure was 
defined as the minimum plateau distance in 3-D space between the two leaflet edge 
markers after end-diastole (t= 0). 
Results: Control and Phenol groups were similar in terms of animal weight, ejection 
fraction, LV pressure, LV dP/dt, HR, and end-diastolic volume. In Control, the AML had a 
compound sigmoid shape during valve closure, but with Phenol the leaflet was entirely 
concave to the atrium. 
Control Phenol P-value 
MAAMAX (Cm’) 8.73f.92 8.83zbO.95 NS 
MAA-red (%) 12.2~3.7 12.2r3.9 NS 
Pi-e-systolic MAA-red (%) 72r6 47+31 ,039 
MV Closure (msec) 31ill 60?21 ,003 
Conclusion: Phenol ablation of MA and AML muscle decreased pre-systolic MAA 
reduction, delayed leaflet coaptation, and altered AML shape, suggesting that myocardial 
fibers on the atrial side of the valve influence the 3-D dynamic geometry and shape of the 
MA and AML. Such interactions should be considered in the rationale and design of 
newer forms of mitral valve repair. 
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1115-106 Repositioning of the Papillary Muscles Using External 
Myocardial Devices: A Novel Approach to Repair of 
lschemic Mitral Regurgitation. 
Judy Hung, J. Luis Guerrero, Mark D. Handschumacher, Suzanne Sullivan, Gregory E. 
Supple, Robert A. Levme. Massachusetts Gener..l.tfospital, Boston, MA 
Background: Mitral ring annuloplasty is used to reduce ischemic mitral regurgitation 
(MR), but is not always effective as it does not address papillary muscle (PM) displace- 
ment assocx&d with ischemic MR. We tested the hypothesis that repositioning the 
papillary muscles (PMs) can effectively reduce ischemic MR. 
Methods: Two types of external devices were tested. The first was a Dacron patch 
sewn over the infarcted epicardium and PM. It contains a balloon that when inflated with 
saline, pushes the myocardium Inward and toward the annulus, repositioning the dis- 
placed PM toward its normal position nearer the mitral valve-ventricular axis. The sec- 
ond used external Dacron-covered disks anchored together by artificial chordae. Three 
sheep were examined at baseline, 8 weeks post myocardial infarction (Ml) from ligation 
of left circumflex artery (LCX) and following device placement (3 Patch and 2 Disk). MR 
and LV volumes were assessed by Doppler and quantitative echocardiography. 
Results: MR developed in all animals 8 weeks following ligation of LCX (.46 i .45 to 8.7 
jr 1.4 ml/beat, p<.OOl). The myocardium underlying the ischemic PM visibly bulged pos- 
teriorly and away from the center of the LV. The mitral leaflets ware tented toward the LV 
apex, forming the incomplete mitral leaflet closure (IMLC) pattern. Placement of patch 
and disk (fig.) devices repositioned the PM toward the center of the LV. This led to signcf- 
icant decreases in MA volume (8.7 r 1.4 to 2.5 + 1.1 mlibeat), IMLC area (.38 ? .04 to 
09 t .08 cmZ), LV end-dtastolic (70 ? 6 to 60 -4 ml) and LV end-systolic (38 2 2 to 35 t 1 
ml) volumes following device placement. 
Conclusion: Repositioning of the papillary muscles using external devices is a poten- 
tially effective approach for reducing ischemic MR, and avoids limitations associated with 
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Conclusion: A disparity between height of AML and ANN appears to be more predictive 
of post MV repair SAM. A surgical approach to reduce the AML height when appropriate 
would further obviate the complication. 
I1 15-109 Geometrical Correction Improves Accuracy of the 
lnteraliasing Distance Method for Quantifying Mitral 
Regurgitation 
Dimitri Deserranno, Marta Sitges, Neil L. Greenberg, Takahiro Shiota, Michael Jones, 
James D. Thomas, Mario J. Garcia. Cleveland Clinic Foundation, Cleveland, OH, The 
National institutes of Health, Bethesda, MD 
A new method based on the proximal flow convergence (FG) principle using the distance 
between the two first aliasing boundaries (interaliasing distance = IAD) has been pro- 
posed to quantify mitral regurgitation (MR). This has been proven to give good estimates 
of regurgitant flows without the need to locate the orifice. However, hemispheric assump- 
tions do not always stand, leading to errors in estimations. We aimed to find a correction 
to deal with this problem and apply it for the quantification of MR in an animal experi- 
mental model. 
Methods: A correction factor was obtained from Computational Fluid Dynamics simula- 
tions (CFD). CFD simulations for different orifices ( diameter 2 - 8 mm), angles ( 90 - 210 
degrees) and flow rates ( 10 - 225 ml/s) were calculated. Centerline velocity profiles 
were examined, and compared to the ideal profiles corresponding with hemisperical 
isovelocity contours. Based on these results a new correction was proposed as follows: Q 
= 4.3 x*dl80* IAD’-e ‘V ,+, ‘VT1 I Vmax, where a is the angle between the two sides of 
the FC, IAD is the interaliasing distance of the FC, VNq is the Niquist velocity, VTI is the 
velocituy-time integral and Vmax the peak velocity of the regurgitant flow. This correction 
function was applied for MR quantification III sheep. MR was surgically created in 8 
sheep. Color Doppler M-Mode recordings along the centerline of the FC were obtained at 
baseline and after blood, angiotensin and nitroprusside infusions. Regurgitant volumes 
(RV) obtained from electromagnetic flow probes (EM) placed around the aortlc root and 
at the mitral annulus were used as reterence standards. 
Results: RV ranged from 2 to 27 ml in the sheep. Both corrected and uncorrected IAD 
method orovided aood correlations of actual RV. However. the error in estimation (A) was 
lower fo; the corrected IAD method (see Table) 
RV (ml) r A (ml) 
II 15-I 07 Real-Time 3-D Echo Methods for Quantification of Aortic 
Regurgitation in a Chronic Animal Model 
Xiaokui Li, Jun Li, Michael Jones, Crispin H. Davies, David J. Sahn. Oregon Health 
Sciences University: Portland, OR, LAMS-NHLBI, Bethesda, MD 
Background: We tested the use of computing the difference between left (LV) and right 
(RV) ventricular stroke volumes (SV) obtained with a real time 3-dimensional (RT3D) 
Imaging system for estimating the severity of aortic regurgitation. Methods: The aortic 
valve was partially resected in 51uvenile sheep 6 months before the study, producing aor- 
tic regurgitation (mean regurgitant fraction = 0.51). Simultaneous hemodynamlc and 3D 
echo images were obtained on open-chest animals with aortic (Ao) and pulmonary (PA) 
flows derived by Ao and PA electromagnetic (EM) flow meters balanced against each 
other. Volume loading, sodium nltroprusside and angiotensin were used to produce a 
total of 16 different hemodynamic states. Epicardial scanning was done with a 2.5MHz 
probe positioned to sequentially record first RV and then LV cavities. Cavity volumes 
were determined from angled slices (B-scans) and parallel slices (C-scans) with each 
ventricular cavity divided mto 9 segments using a modified Simpson’s rule technique. 
Aortic regurgitant volumes were determined from 3D by computing and then subtracting 
RV from LV SVs (Diastolic volume minus systolic volume) and then compared to Ao - PA 
EM SV, Results: There was close correlation between both RV and LV SVs by RTBD 
and EM methods ([C-scans: RV, r = 0.97, SEE = 1.65ml; LV, r = 0.98, SEE = 2.60ml; 
p<O.OOOi][B-scans: RV, r = 0.77, SEE = 2.78ml, p = 0.0003; LV, r = 0.95, SEE = 3.55ml, p 
= O.OOl]), although, because of the small size of the RV visualization, the correlation was 
closer for C-scans than B-scans for RV SV. As a result, the best overall correlation 
between 3D and EM regurgitant fractions was obtained for C-scan data (C-scans: r = 
0.97, SEE = 2.7%). Conclusion: In this animal model, RT3D imaging had the ability to 
reliably quantify both LV (8. and C-scans) and RV (C-scans best) SVs and to assess the 
severity of aortic regurgitation. 
1115-I 08 Role of Anterior Mitral Leaflet in Genesis of Systolic 
Anterior Motion (SAM) Complicating Mitral Valve Repair 
Pravin M. Shah, Aidan A. Raney. Haag Heart Institute, Newport Beach, GA 
Background: Earlier studies have emphasized a possible role of posterior leaflet height 
on development of post MV repair SAM, resulting in the surgical technique of posterior 
leaflet reduction with sliding annuloplasty. 
Hypothesis: The anterior mitral leaflet (AML) height is equally important as the poste- 
rior mitral leaflet (PML) in development of post MV repair SAM. 
Method: Forty patients with myxomatous MV prolapse with multiplane TEE performed 
intraoperatively were analyzed. The echo parameters in 32 without SAM (No SAM 
group) were compared with eight with SAM (SAM group). The echo measurements 
included heights of AML, PML and the mitral annulus (ANN) diameter in four chamber 
and long axis views before and after MV repair. The dimensions in the two views were 
averaged. 
Results: Prior to MV repair, the SAM group as compared to the NO SAM group exhib- 
ited a greater height of AML (pcO.O4), the height of PML was not significantly different 
(p=O.O8) and the annular dimensions were similar. (Table 1) Following MV repair, the 
SAM group had consistently greater height of AML (p=O.O05) and smaller ANN dimen- 
sions (p=O.OOi). (Table 2) Similarly, the difference between AML and ANN expressed as 
AML-ANN in post MV repair was significantly greater in the SAM group, as was the differ- 
ence between combined heights of the AML and PML versus ANN. 
EM 9.95i5.2 
IAD 1425 0.90* 4.5 
Corrected IAD 9.9t3.3 032* 3.0 t 
* ~~0.05 versus EM; t ~~0.05 versus IAD 
Conclusions: IAD method provides good estimations of RV. The accuracy of this 
method can be significantly improved by adding a correction for the change in the geo- 
metrical shape of the flow convergence region. 
POSTER SESSION 
1149 Aortic Valve Stenosis 
Monday, March 19, 2001, 3:00 p.m.-%00 p.m. 
Orange County Convention Center, Hall A4 
Presentation Hour: 4:00 p.m.-500 p.m. 
1149-103 Hemodynamic Progression of Mild/Moderate Aortic 
Stenosis and Aortic Valve Sclerosis: a 12-Year Follow-Up 
Echocardiographic Study 
Francesco Antonini-Canterin, Pompilio Faggiano, Anna Gualeni, Eugenio Cervesato, 
Raffaele lengo, Daniela Pavan, France Macor, Renata Mimo, Vittorio Dall’Aglio, Gianluigi 
Nicolosi. Cardiologia, ARC Ospedale Civile, Pordenone, /ta/x Ospedale S Orsola, 
Brescia, /ta/y 
Background. Several studies have investigated in the last years the progression of mild/ 
moderate aortic stenosis (AS). These studies however are usually limited by the small 
number of patients and by the short duration of follow-up. In addition little is known about 
the progression over time of aortic valve sclerosis without significant outflow ostruction. 
Methods. We analyzed from our echocardiographic database (1988-2000) all adult 
patients with an initial peak jet aortic velocity ~1.5 m/s and 5 3.9 m/s and with at least two 
examinations 2 6 months one apart of the other. Patients with coexisting aortic regurglta- 
tion more than moderate were excluded. The study population includes 1227 patients 
(658 males; mean age 65~12) followed for 48~33 months (range 6.140), each one with a 
mean of 4+3 echocardiographic examinations (range 2-21). If a patient underwent aortic 
valve replacement, the last examination before the operation was considered. According 
to the initial Doppler velocity patients were divided in 3 groups: A) Aortic valve sclerosis 
(velocity ~2.0 m/s): N=463, B) Mild AS (velocity:Z.l-3 m/s): N= 538, C) Moderate AS 
(velocity:3.1-3.9 m/s): N=226. 
Results. Mean increase of jet velocity was 0.1210,25 mislyr in the entire population, 
0.07&0.16 in group A, 0.1 lkO.27 in group B, 0.25+0.30 in group C (p<O.OOl). A rapid pro- 
gression (20.3 mlslyr) was observed in 5.4% in group A, in 13.6% in group B and in 
33.6% in group C (p<O.OOl). Mean reduction of aortic valve area was 0.06iO.l cm2iyr in 
group A, 0.07+0.1 in group B, 0.08+0.1 in group C (p<O.OOl). During follow-up a severe 
AS, defined as jet velocity 24 m/s, was reached by 2.2% of patients in group A, 14.7% in 
group B and 60.2% in group C (p<O.OOl). Among patients with a minimum follow-up 
more than 5 and 10 years respectively, a severe AS was reached by 6.8% and 15.4% 
(group A), 26.3% and 32.0% (group B) and 78.6% and 87.5% (group C)(p<O.Ol). 
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Conclusion. Our study demonstrates in a large series of patients that long-term progres- closing (O.Oli-0.1 vs. 0.3l+O.P/%systole, pc.001). Over 19rlO months follow-up, the non- 
sion is more rapid in moderate AS than in mild ones. A large majority of moderate AS severe patients did well hemodynamically without AVR; with severe AS, 5/6 with AVR did 
becomes severe in 5 years. Also patients with aortic valve sclerosis however tend to well, 4/5 without AVR did poorly (pulmonary edema, cardiac death). 
develop a true AS in a relatively small period of time. Conclusion: Measures of AV pliability at rest from dynamic variations in instantaneous 
AVA (vt A+) can provide comparable information to the AVA response to Dobutamine in 
1149-104 ECG Changes and Microcirculatory Dysfunction in Aortic patients with LV dysfunction evaluated for AS. These measures can be tested for poten- 
Valve Stenosis tial to predict outcome of therapy in such patrents. 
Kim Rajappan, Jamil Mayet, Ornella Rimoldi, Paolo G. Camrci, Desmond J. Sheridan. 
Academic Cardiology Unit, St. Mary’s Hospital London, United Kingdom, MRC Clinical 
Sciences Centre, Hammersmith Hospital, London, United Kingdom 
Background: Patients with aortic stenosis often have ECG changes suggestive of 
ischemia in the absence of significant coronary artery disease. This may be due to 
abnormalities of the coronary microcirculation. Positron emission tomography (PET) 
allows the non-invasive assessment of coronary microvascular function. The aim of this 
study was to investigate the relationship between ECG changes and coronary vasodilator 
reserve (CVR), an index of microcirculatory function, using standard ECG and PET. 
Methods: Sixteen patients with aortic stenosis and no significant coronary artery dis- 
ease at angiography were studied. Myocardial blood flow (MBF) was measured using a 
high sensitivity PET scanner (EXACT 30) and oxygen-15 labeled water, both at rest and 
during hyperemia (i.v. dipyridamole 0.56mgikg). CVR was calculated as hyperemic MBW 
resting MBF after correcting the latter for resting rate pressure product. A standard 12. 
lead EGG was recorded in each patient at the time of PET and the presence of ST 
depression and/or T wave abnormalities (flattening or inversion) on the resting tracing 
was noted. Results: 6 patients had no STfl wave abnormalitres, 1 had ST depression 
only, 8 had T wave abnormalities only and 1 patient had both ST and T wave changes. 
CVR in the 6 subjects with no ST/T wave abnormalities was 1.87 f 0.35, and in the 10 
subjects with any ST/T wave abnormality was 1.41 r 0.32 (Mean * SD). A single factor 
ANOVA showed that the CVRs of the two groups were significantly different (p=O.O18; 
Fx7.18). Conclusions: Our results suggest that the presence of ST/T wave abnormai- 
likes on the resting 12-lead EGG is associated with a more severe impairment in CVR in 
patients with AS. In the absence of epicardial stenosis, the impairment of CVR is indica- 
tive of microcirculatory dysftinction. 
1149-105 Response of Aortic Stenosis to Dobutamine infusion Can 
Be Predicted From Resting Data 
Claudia Blais, Philippe Pibarot, Jean G. Dumesnil, Marie Arsenault. Quebec Heart 
Institute, Sainte-Fey, PQ, Canada 
Background: Dobutamine infusion is routinely used to differentiate fixed from flexible 
aortic stenosis. We hypothesized that the dynamic change in effective orifice area during 
ejection at rest might be used to predict the valve area behavior during dobutamine. 
Methods: Thirteen patients with aortic stenosis underwent Doppler-echocardiographic 
examination at rest and during dobutamine infusion. The valve area and flow rate were 
measured at each 30 ms during ejection under resting conditions. From these resting 
data, we determined the percentage change in instantaneous valve area per change in 
flow rate (%AEOAilAQi) from the onset to the peak of systole and compared it to the per- 
ceniage change in mean valve area per change in mean flow rate (%AEOAm/AQm) 
obtained during dobutamine. 
Results: There was a high (r=O.71) correlation between the resting %AEOAiiAQi and the 
dobutamine %AEOAm/AQm. Patients with a flexible stenosis defined as a relative 
increase in mean valve area during dobutamine >lO % (n=9) had a significantly higher 
resting %AEOAi/AQi compared with patients with a fixed stenosis (relative increase in 
valve area < 1 O%, n=4): 29 i 5 vs. 23 + 5 %/lOOmls-‘, p=O.O49. Moreover, a %AEOAi/ 
AQi c 25 %IlOOmls“ identified a fixed stenosis with a positive predictive value of 85%. 
Conclusion: The response of aortic stenosis to dobutamine infusion can largely be pre- 
dicted from the analysis of the changes in valve area during ejection at rest. This new 
approach could potentially decrease the need for dobutamine stress echocardiography in 
patients with aortic stenosis. 
1149-106 Aortic Stenosis With Poor Ventricular Function: Aortic 
Valve Pliability at Rest Predicts Results of Dobutamine 
Testing 
Chi-Ming Chow, Robert A. Levine, Mark D. Handschumacher, Emmanuel Messas, Micha 
S. Feinberg, Ehud Schwammenthal. Massachusetts General Hospital, Boston, MA, 
Sheba Medical Center, Tel Hashomer, lsrael 
Background: Patients with limited aortic valve (AV) excursion and LV dysfunction 
present a dilemma: Is aortic stenosis (AS) fixed and severe, with potential for LV improve- 
ment with valve replacement (AVR)? Or is the opening of a pliable valve mainly limited by 
LV dysfunction, predicting little benefit from AVR? Recent studies have used dobutamine 
stress echo (DSE) to separate severe and nonsevere AS based on AV area (AVA) 
changes with increased flow. Dynamic changes in AVA over systole, however, can be 
obtained at rest from the instantaneous ratios of subvalvular to stenotic jet velocities (v, / 
v,). We therefore tested the hypothesis that these dynamic changes in instantaneous 
AVA can predict the AVA response to DSE, and separate severe AS (less pliable valve 
with prolonged rise in AVA) from nonsevere (rapid rise to maximal AVA with little subse- 
quent change). 
Methods: We studied 17 patients with’limited AV motion and LV dysfunction (mean EF 
30%) studied at rest and with DSE to 20mcglkgimin (nonsevere AS by DSE defined as 
AVA increase >0.3cm2 to values >l .Ocm’). 
Results: By DSE, 11 patients had severe and 6 nonsevere AS (AVA: 69k.2 to .74*.2 vs 
.75f.l to 1.1~.lcm’). All patients with severe AS by DSE had delayed rise to peak vtivs; 
those with nonsevere AS had a rapid rise to peak v,/v, (at Tmax = 16.215.0 vs. 
65.9k23.9 % of systole, p<.OOl) and had a flat or negative slope from 10% systole to AV 
10% Time (% Systole) 
1149-i 07 lntraoperative In Situ Measurement of Aortic Valve Area in 
Patients With Aortic Stenosis: A Comparison With 
Echocardiographically Derived Variables 
Roland R. Brandt, Manfred Jung, Erwin P. Bauer, Hassan Bahavar, Christian W. Hamm. 
Kerckhoff Heart Center, Bad Nauheim, Germ&y 
Background: Aortic valve area (AVA) is a useful index for assessing aortic stenosis 
severity. Calculation with the continuity equation (CE) from transthoracic Doppler 
echocardiographic data and direct planimetry with transesophageal echocardiography 
(TEE) are accepted methods for determination of AVA. In this study, we compared AVA 
determined by both echocardiographic methods with intraoperative in-situ measure- 
ments. Methods: Using multiplane TEE, AVA was blanimetered at the level of the leaflet 
tips in the short-axis view and also calculated with the CE by one observer. At surgery, an 
inflatable balloon was placed below the valve and the leaflets were opened employing a 
graded traction force to allow for direct measurement of the anatomic AVA by a second 
blinded observer. Results: All 18 patients (mean age 69 + 7 years) were in sinus rhythm 
with an ejection fraction (EF) of 58 * 12% (range, 25-70). A good correlation (I = 0.77, 
SEE = 0.17 cm>) was found between planimetered AVA (0.71 * 0.20 cmz) versus ana- 
tomic AVA at surgery (0.69 + 0.22 cml): y = 0.85x + 0.09. The mean difference between 
both methods (Bland-Altman analysis) was 0.02 f 0.14 cm2, However, a poor correlation 
(r = 0.44, SEE = 0.32 cmz) was observed between AVA by GE (0.63 i 0.16 cm2) versus 
anatomic AVA at surgery due to underestimation of the anatomic AVA in patients with a 
low EF. Conclusion: Direct measurement of anatomic AVA at surgery is feasible. The 
planimetered AVA by TEE.corresponds closely to the anatomic AVA measured,& surgery 
while the AVA by CE may underestrmate the anatomic AVA due to flow-dependence. 
1149-l 08 Severe Pulmonary Hypertension in Patients With Severe 
Aortic Valve Stenosis: Clinical Profile and Prognostic 
Implications 
Joseph F. Malouf, Charles J. Mullany, Maurice E. Sarano, Kent Ft. Bailey, Patricia A. 
Pellikka, Jae K. Oh, A J. Tajik. Mayo Clinic, Rochester, MN 
Severe pulmonary hypertension (PHT) secondary to severe aortic valve stenosis (AS) is 
uncommon and has not been well evaluated. We studied the clinical and echocardio- 
graphic profile of this subgroup of patients (pts) to better characterize the clinical and 
prognostic implications of PHT in severe AS. Methods: The Mayo Clinic echo database 
from 1987-1999 was searched for pts with severe AS [aortic valve area (AVA) < 1 cm* 
and associated severe PHT [tricuspid regurgitation velocity (TRV) t 4misecj. Exclusion 
criteria included the presence of mitral stenosis,severe mitral regurgitationprosthetic 
heart valveand pulmonary disease. Results: There were 46 pts (23 man; age 78 i. 8) of 
whom 36 pts (78%) were in NYHA Ill-IV. Ten pts (22%) had a history of prior Ml. AVA was 
0.56 2 0.17 cm2 and TRV was 4.18 r 0.25 misec (pulmonary artery pressure (PAP) > 70 
mmHg). Mean LV EF % was 42 * 18%. The mitral deceleration time (DT) was measured 
in 37 pts. The mean DT was 165 & 40 msec with 15/37 (41%) having a DT < 150 msec. 
Thirty seven pts (80%) underwent valve replacement (20 pts AVR and 17 pts AVR + 
CABG). The 30 day operative mortality was 16% (6137). Diabetes was the only significant 
predictor of operative mortality (P=O.O5). Late deaths postop occurred in 8/31 pts (26%, 5 
noncardiac) during a median follow-up of 377 days. Seven of the 9 pts (78%) who did not 
undergo AVR died during a median follow-up of 273 days from time of index echo and 5 
deaths were cardiac. PAP decreased significantly (P= 0.0001) in 23 surviving pts within 
one month after surgery (PAP < 50 mmHg in 1 i/23 pts). There was a significant inverse 
association between pre AVR DT and post AVR decrease in PAP (P=O.O5). AVR was also 
associated with significant improvement in the EF (9 ? 16 %; P= 0.0061). However, this 
did not correlatewith decrease in PAP (P=NS). Conclusions: 1. Severe PHT secondary 
to AS portends a poor prognosis 2. Severe PHT is associated with increased operative 
mortality regardless of LV function or CAD. 3. The mechanism of severe PHT in AS 
appears to be severe diastolic dysfunction. 4. Reduction in PAP after AVR is more srgnif- 
icant in pts with shorter DT pre AVR 
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Does Isolated Aortic Valve Sclerosis Predict Decreased 
Survival? 
Prabhakara S. Heggunje, Jignesh S. Shah, Michael J. Wade, Agha J. Ahmed, Abid 
Hussain, Paul Kelly, Paul Shanahan. Veterans Affws Medical Center, Syracuse. NY 
SUNY Upstate Medical University, Syracuse, NY 
Background: Prior studies suggest that aortic valve sclerosis is a marker of atheroscle- 
rosis. However, it is unclear whether aortic valve sclerosis in the absence of coronary 
artery disease (CAD) affects survival. Methods: We assessed 2411 consecutive 
echocardiograms performed at our institution between January, 1994 and December, 
1995 for the presence of aortic valve sclerosis (AVS). Patients with aortic stenosis (gradi- 
ent > 16 mm/hg) were excluded (N=130). Patients with AVS were divided into those with 
documented CAD (N=327) and those without known CAD at baseline (N=663). The Inci- 
dew? of death from any cause over a pwod of 5 years was compared between the iwo 
groups and 244 age matched controls with neither AVS nor CAD at baseline. Results: 
Aortic valve sclerosis was diagnosed in 43% of this elderly, predominantly male popula- 
tion with a mean age of 73 years. Cumulative 5-year mortality was 38% for patients with 
AVS versus 31% for patients without AVS (P=O.OOl). Patients with AVS and CAD had 
higher mortality (45%) than patients with AVS without CAD (35%), (P=O 004). When 
patients with AVS without known CAD were compared to patients with neither AVS nor 
CAD, there was no difference in B-year mortality (35% vs 41%, p=O.O9). Among the 
patients without known CAD, there was still no difference in mortality between patients 
with AVS and no AVS after adjusting for baseline differences in the prevalence of diabe- 
tes. hypertension, renal failure, advanced chronic obstructive airway disease and termi- 
nal malignancies(Odds Ratio=0.79; 95% confidence interval=0.56 - 1 .ll). Conclusion: 
These findings suggest that the isolated aortic valve sclerosis in the absence of known 
coronary artery disease is not associated with a decreased survwal on long term follow 
UP. 
806-3 
9:oo a.m. 
Degenerative Aortic Valve Disease as an Atherosclerotic 
Process: The Correlation Between Aortic Valve Calcification 
and Coronary Artery Calcification 
Francisco Lopez-Jimener, David King. Juan C. Londono, Gervasio A. Lamas, Michael 
Gaziano, Scott Solomon, Arthur S. Agatston. Brigham and Women’s Hospital, Harvard 
medical School and MAVERIC, Boston, MA. Mount Sinai Medical Centec Miami Beach, 
FL 
Aortic valve calcification IS the main substrate for the development of degenerative aortic 
valve disease. We sought to investigate the Independent association between the degree 
of aortic valve calcification and the severity of coronary artery disease as measured by 
the coronary calwm score, a known surrogate for plaque volume. Methods: We pro- 
spectively analyzed 897 consecutive patients who visited a cardiac prevention center. 
Patients were studied with an electron beam tomography scan using 30 to 40 contiguous, 
3 mm slices. Each image was acquired in 100 msec. Coronary calcium and aortic valve 
calcification were measured using the total volume and the calcium scores using the 
Agatston method. Patients with history of coronary stent, aortlc valve replacement and 
coronary bypass were excluded (n=72). Results: Patients were 57tll years old, 31% 
women. Adjusted by age, patients with coronary artery disease were 2.7 times more 
likely to have a significant calcium volume in the aortic valve, p=O.O06. Also adjusted for 
age, coronary calcium volume was correlated with aortic valve calcium volume, rx0.31, 
p<O.OOOl. Patients in the 5th quintile of coronary calcium score were 4 times more likely 
to have calcium in the aortic valve than patients in the 1st quintile after adjusting for age, 
p=O.O007. In patients 55 years or younger, those in the 5th quintile of coronary calcium 
score had a relative risk of 12.6 for having aortic valve calcification, when compared to 
those in the 1st q&tile, p=O.O08. The degree of aortic valve calcification was significantly 
higher according to the quintile of coronary calcium score: First quintile 5.023; second 
1.4+1; third 19.Oi7; fourth 38.529, fifth 100.0&27; p<O.OOOl. Furthermore, patients with 
aortic valve calcification were more likely to have hypertension, diabetes and dysllpi- 
demia than patients without calcium in the aortic valve, p<O 05. Conclusions: Aortic 
valve calcification is strongly correlated with the burden of coronary artery dwase as 
measured by the level of coronary calcium. This association suggests that many cases of 
aortic sclerosis or degeneratwe aortic valve disease may share a similar etiology with 
coronary atherosclerosis. 
806-4 
9:15 a.m. 
Relation of Aortic Valve and Mitral Anular Calcification to 
Cardiovascular Mortality in American Indians: The Strong 
Heart Study 
Javier Gonzalez, Richard B. Devereux, Vittorio Palm&i, Mary J. Roman, Jennifer E. Liu, 
Lyle Best, Elisa T. Lee, Richard R. Fabsltz, Barbara V. Howard. Weill Cornell Medical 
Centeer, New York, NY 
Background:Several studies have shown associations between calcification of the aortlc 
valve or mitral anulus and subsequent cardiovascular events. However, no study has 
analyzed the associations of both in the same population, adjusted for each other and 
standard risk factors, with subsequent cardiovascular mortality. Methods: Echocardio- 
graphy was performed in 2,582 American Indian participants aged 47 to 81 years in The 
Strong Heart Study (study of cardiovascular risk factors and disease in 13 American Indi- 
ans tribes). The prevalence of fibrocalcific aortic valve and mitral annular calcification and 
their relationship to cardiovascular mortality was analyzed by Cox regression models 
adjusted for the presence of cardiovascular risk factors. Results: Cardiovascular mortal- 
ity, during a mean of 3.1 years of follow-up (0.3 % lost to follow up), was associated inde- 
pendently with age, systolic blood pressure, coronary heart disease and diabetes 
mellitus (pcO.001). Addition of aortic valve calcification to the multivariate analysis 
showed it to be a predictor (RRz1.9, 95% confidence interval 1.1-3) of cardiovascular 
mortality (~~0.02) Alternative regression models adding or substituting mitral annular cal- 
cification showed it not to be an independent predictor of cardiovascular mortality 
(~~0.31 in both analyses). When mitral calcification was included in the model, fibrocal- 
cific aortic valve remained an independent predictor (RR=2.0, 95% confidence interval 
1.2-3.4, p=O.O15) of cardiovascular mortality. Conclusions: Fibrocalcific aortic valve sig- 
nificantly predicts increased cardiovascular mortality independently of age, gender, sys- 
tolic blood pressure, body mass index, diabetes mellitus, lipid levels, smoking and 
presence of mitral annular calcification, whereas mitral calcification does not. These find- 
ings also suggest that the relation of aortic valve calcification to atherosclerotic cardio- 
vascular disease IS not completely mediated by standard risk factors. 
806-5 
9:30 a.m. 
Aortic Sclerosis, Inflammation, and Adverse Cardiac Events 
at 12 Months: A Prospective Study 
Harish R. Chandra, Nivedita Choudhary, Carol O’Neill, Peter 8. George, Sreenivasulu R. 
Gangasani, Lynn Cronin, Pamela A. Marcovitz, William W. O’Nelll. William Beaumont 
Hasp&/, Royal Oak, M/ 
Background: Recent studies have shown an association between aortic sclerosis and 
adverse cardiovascular outcomes which is not fully understood. 
Methods: We prospectively evaluated the association between aortic sclerosis and sys- 
temic markers of inflammation, C-reactive protein (CRP) and fibrinogen, in relation to 
adverse cardiac events (CE) in 415 patients (mean age 68 i 15 yrs, 54% male) admitted 
to a chest pain center between 3/99 and 6/99. All had 2D echocardiography (echo), blood 
work and clinical evaluation Echoes were graded for degree of aortic sclerosis including 
valvular thickening and calcification: none, mild (1 leaflet involved), moderate (2 leaflets 
involved) and severe (3 leaflets involved). Aortic stenosis (peak velocity 2 2mls) was 
excluded. 12 month follow-up was performed for CE comprising death and myocardial 
infarction (Ml). Univariate and multivariate analyses were performed. 
Results: 51% had no aortic sclerosis, 36% had mild, and 13% had moderate or severe 
aortic sclerosis. Overall there were 61 CE (15%) including 46 deaths (11%) and 19 Ml 
(5%). There was a statistically significant, incremental incidence of GE with ascending 
tertiles of CRP and increasing severity of aortic sclerosis (Figure). The highest event rate 
was seen in patients within the highest tertile of CRP and moderate to severe aortic scle- 
rosis. On multivariate analysis the independent predictors of death or MI at 12 months 
were age (OR: 1.04, p=O.O025), known history of coronary artery disease (OR: 3.05, 
p=O.O012), ascending tertiles of CRP (OR: 2.03, p=O.O005), and increasing severity of 
aortic sclerosis on baseline echocardiography (OR: 1.50, p=O.O4). 
Conclusion: This study shows a strong and positive association between aortic sclero- 
sis. inflammation, and adverse cardiac outcomes. The association between aortic sclero- 
sis and cardiac events appears to be mediated by systemic inflammation. 
806-6 
9:45 a.m. 
Expression of Angiotensin II Receptors in Human Aortic 
Valve Lesions: A Potential Role of the Renin-Angiotensin 
System in the Pathogenesis of Aortic Stenosis 
David M. ShavelIe, Thomas 0. McDonald, Catherine M. Otto, Kevin D. O’Brien. University 
of Washington, Seattle, WA 
Background: Lesions of valvular aortic stenosis (AS) share many similarities to athero- 
sclerosis, including the presence of an inflammatory cell infiltrate and lipoprotein 
deposition. We have shown recently that the angiatensin converting enzyme (ACE) pro- 
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tein is present in human AS lesions and co-localizes with retained lipoproteins. This 
study was undertaken to determine whether receptors for angiotensin II (Angll), the 
enzymatic product of ACE, are present in AS lesions. 
Methods: Ao!tic valves were obtained from 21 adults at autopsy (n=17) or aortic valve 
replacement (n=4). lmmunohistochemistry was performed on adjacent sections using 
commercially-available antibodies for ACE, apolipoprotein B (apoe), macrophages (CD- 
68), contractile proteins (u-actin) and for the two predominant Angll receptor subtypes 
(AT-1 and AT-2 receptors). 
Results: Non-lesioned areas of the aortic valve fibrosa did not contain detectable AT-1 or 
AT-2 receptors. In contrast, both AT-1 and AT-2 receptors were present in aortic valve 
lesions. AT-2 receptors were more prevalent than AT-1 receptors in mild AS lesions. AT-1 
receptors, when present, were localized to a subset of a-actin-expressing fibroblasts 
(myofibroblasts). In addition, myofibroblasts expressin’g AT-1 receptor were prominent in 
the leaflet tips of both normal and lesion-containing valves. The extent of AT-1 receptor 
expression correlated with AS lesion severity. 
Conclusion: This study demonstrates that: 1) AT-1 receptor expression in aortic valve 
fibroblasts is restricted to a subset of valve fibroblasts that express contractile proteins 
(a-actin) and 2) the extent of AT-1 receptor expression correlates with AS lesion severity. 
These findings are consistent with the hypothesis that the renin-angiotensin system plays 
a role in the pathogen&s of AS. 
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1215103 Natriuretic Peptides Are Useful for the Identification of 
Severe Non lschaemic Mitral Regurgitation 
Nicholas P. Jenkins, Anita Bhattacharya, Christopher Reeves, Brian G. Keevil, Simon G. 
Ray. Department of Cardiology, Wythenshawe Hospital, Manchester, United Kingdom 
Background: Recent clinical studies have highlighted the importance of early surgical 
intervention in patients with significant mitral regurgitation. Routine echocardiographic 
methods for assessing severity of mitral regurgitation can be limited in the presence of 
eccentric jets or poor image quality. We assessed the value of atrial natriuretic peptide 
(ANP) and brain natriuretic peptide (BNP) as markers of severity in chronic non- 
ischaemic mitral regurgitation. 
Methods: We recruited 20 patients with severe and 20 patients with non-severe mitral 
regurgitation. Patients with prosthetic or other valve lesions, ischaemic heart disease, 
renal dysfunction, and cardiomyopathy were excluded. Severity was assessed by calcu- 
lating the regurgitant fraction from the pulsed-wave doppler time-velocity integral and 
cross-sectional area of the left ventricular outflow tract and mitral annulus. Patients with a 
regurgitant fraction of 55% or above were defined as having were mitral regurgitation. 
Enzyme-linked immunosorbant assays were used to measure N-terminal ANP and N-ter- 
minal pro-BNP 
Results: Mean age was 61(12) years and 23(58%) were male. Mean regur- 
gitant fraction was 35(15)% in the non-severe group and 73(1 l)% in the severe group. 
The groups were comparable with respect to age, sex, frequency of atrial fibrillation, and 
left ventricular function. ANP and BNP concentrations were significantly greater in 
patients with severe than non-severe mitral regurgitation (ANP mean 9470(734) 
fmol/ml vs 4748(828) fmoliml P&001, BNP 1401(206) fmol/ml vs 524(75) fmoliml 
PcO.001 respectively). The regurgitant fraction was highly correlated with ANP (r=0.610, 
PcO.001) and BNP (rxO.547, P<O.OOi). Receiver-operator characteristic curves for 
detecting severe mitral regurgitation gave an area under the curve of 0.86 (95% Cl 0.74- 
0.98) for BNP; and 0.82 (95% Cl 0.69-0.96) for ANP. The optimal cut-off for BNP was 520 
fmolil, corresponding to a sensitivity of 95% and specificity of 63%. 
Conclusions: ANP and BNP are elevated in patients with severe mitral regurgitation rel- 
ative to those with lesser degrees of regurgitation, and may be useful clinically for 
assessment of severity. 
1215-104 Angiotensin-Receptor Blockade in Mitral Regurgitation Due 
to Mitral Valve Prolapse: Mechanism of Effect 
Jean-Francois Avierinos, Helen Thomson, Karl Dujardin, Dania Mohty, Maurice E. 
Sarano. Mayo Clinic, Rochester, MN 
Background: The effect of vasoactive treatment on mitral regurgitation (MR) due to 
organic mitral valve disease is disputed and its mechanism is uncertain. Methods: To 
define the magnitude and mechanism of effect of angiotensin-receptor blockade (ARB) in 
organic MR, in 57 patients with mitral valve prolapse the regurgitant volume (RVol) and 
orifice area (ERO) were measured using 3 quantitative Doppler-Echocardiographic meth- 
ods, before and 4 hours after administration of oral ARE. In 26 patients Losartan 50 mg 
was administered whereas in 31 patients Candesartan 32mg was given. The mean 
pretreatment RVol and ERO were respectively 77(22) mL and 41(14) mm2. Results: 
After administration of ARB the systolic blood pressure decreased by 14(13) mmHg and 
the RVol by 15(8) mL or 20(9)% (both P<O.OOOl). However, there was no direct correla- 
tion between the degree of decrease in systolic blood pressure and that of RVol. The 
direct determinants of the decrease in RVol were the change in ERO, in regurgitant dura- 
tion and in regurgitant gradient (all P<O.OOOl). The magnitude of change in FtVol was 
12% random, 34% related to change in regurgitant duration, 28% related to change in 
ERO and 25% related to change in gradient. Comparing Losartan to Candesartan, there 
was no difference in change of ERO but the relative change of RVol was larger with Can- 
desartan (-23(g)% vs. -17(8)%, p=O.OOS) due to larger decrease in regurgitant duration 
(-29(32) vs. 0.2(24) msec, p=O.O002) and in regurgitant gradient (-lO(22) vs. -1(13) 
mmHg, p=O.O9). Conclusion: In patients with MR due to mitral valve prolapse acute 
administration of AR6 1) results in significant decrease in RVol, which 2) is unrelated to 
the magnitude of decrease in blood pressure but is related to declines in ERO and regur- 
gitant gradient and duration. 3) Contrasting effects can be observed depending on the 
medication used, due to their variable effect on regurgitant orifice, gradient and duration. 
1215-l 05 Myocardial Lactate Dehydrogenase Patterns in Volume- or 
Pressure-Overloaded Ventricles 
Cornelia Piper, Dieter Horstkotte, Anne K. Bock, Edmund Wudel, Heinz P. SchultheiO, 
Andrea Diimer. Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany, 
Benjamin-Franklin Hospital, Berlin, Germany 
Background: The pyridine nucleotide redox (NADINADH) system is a sensitive indicator 
for the functional status of cellular oxidation. As the NAD/NADH system is closely linked 
to the lactate dehydrogenase (LDH) system the latter can be used to evaluate the myo- 
cardial energy status Increased LDH activity and isoenzyme shift towards LDH, (M-sub- 
units) have been observed in &were heart failure. We assessed myocardial LDH activity 
and LDH isoenzyme pattern of patients (P) with chronic volume or pressure overload due 
to various severities of valvar heart disease (VHD). 
Methods: Total LDH activity was measured by disappearance of NADH at 340 nm and 
LDH isoenzyme pattern by gel electrophoresis in myocardial biopsies taken from 12 (P) 
with valve incompetence (aortic, n=6; mitral, n=6) (regurgitation fraction (RF) 22.55%, 
cardiac index (Cl) 1.8-4.5 mllmin/m2, peak filling rate (PFR) 1 .l-3.4 EDV/s, max. oxygen 
consumption (V02)10-24 liminikg bw) and 12 P with aortic stenosis (pressure loss (PL) 
0.2-2.9 mmHg/ml stroke volume, Cl 2.0-4.4 liminlm”, PFR 0.9-4.0 EDVls, VO, 8-20 ml/ 
minikg bw) As controls, endomyocardium from explanted hearts (EXPL, n=7) with end- 
stage heart failure and without (C, n=6) were examined. 
Results: LDH activity in C was 7.4t1.7 Uimg protein (LDH,: 39.8%+5, LDH, 2.5%? 1.8, 
M-type 17.3%?4). In VHD, mean LDH activity was increased to 10.8k4.7 Ulmg protein 
(p=O.O69) without a significant isoenzyme shift (LDH,: 35.8%1-4.7, LDH, 2.5%+1.7, M- 
type 19.3%?4.6 (p=O.3)). LDH activity in EXPL was 14.8k7.6 U/mg protein (p=O.O3) with 
significant isoenzyme shift towards LDHS (LDH,: 26.4%+5.9, LDH,: 10.5k5.4, p=O.O15; 
M-type 33%? 8.9, p=O.O05). In VHD, increased LDH activity was correlated with impaired 
systolic (Cl, I= -0.45) and diastolic function (PFR, I= +0.55) and decreased oxygen con- 
sumption (VOp, r=-0.37). No significant isoenzyme shift was found in severe VHD. 
Conclusion: LDH activity but not isoenzyme shift may be used to detect energetic imbal- 
ance in VHD early. LDH activities 2 12 U/mg may indicate a critical borderline. 
1215-106 Accuracy and Reliability of the Mitral/Aortic Flow Velocity 
‘Integral Ratio in the Assessment of Mitral Regurgitation 
Severity 
Luigi Ascione, Mario De Michele, Pasquale Guarini, Maria Accadia, Pio F. Tartaglia, 
Cosimo Sacra, Bernardino Tuccillo. Cardiology, Loreto Mare Hospita/, Napoli, /t&x 
Federico /I University, Napoli, /ta/y 
Background The noninvasive assessment of mitral regurgitation severity is still a chal- 
lenge, since the existing echocardiographic methods are either dependent on patho 
physiologic and instrumental factors or time consuming and with a high degree of vari- 
abilityThe present study was designed to evaluate the accuracy and reliability of a Dop- 
pler index, the mitraliaortic flow velocity integral ratio in the estimation of mitral 
regurgitation severity. 
Methods We studied 91 patients (mean age 61 i 14 years; 54% men) with echocardio- 
graphically diagnosed mitralregurgitation. The cause was organic in 23 subjects (10 with 
rheumatic disease and 13 with valvular prolapse) and ischemicifunctional in 68 (37 with 
coronary artery disease and 31 with dilatative cardiomyopathy). Mitral regurgitation 
degree was assessed by 3 methods: the mitrallaortic flow velocity integral ratio, the color 
Doppler jet area, and by calculating the regurgitant fraction used as reference standard. 
Results A good correlation was found between the mitraliaortic flow velocity integral ratio 
and both color Doppler jet area and regurgitant fraction (r = 0.77, and r = 0.75, respec- 
tively). When we divided patients into three groups on the basis of the regurgitant frac- 
tion, the mitrallaortic flow velocity integral ratio significantly increased in proportion to 
mitral regurgitation severity (0.7 + 0.1 for mild regurgitation vs 1 .l i 0.2 for moderate and 
1.5 i 0.3 for severe regurgitation, p < 0.0001). A ratio > 1 identified 28130 patients with 
severe regurgitation (regurgitant fraction > 60%) (sensitivity 93% and specificity 72%), 
whereas all patients with mild regurgitation (regurgitant fraction < 40%) had a ratio c 1 
(sensitivity 100% and specificity 75%). To asse?s method reproducibility, measurements 
were repeated on a subset of 30 subjects with varying grades of mitral regurgitation: the 
intra and interreader coefficients of variation for the ratio were 2.8 and 3.5 %, respec- 
tively. 
Conclusions The present findings suggest that the mitraliaortic flow velocity integral 
ratio is a sensitive and reproducible index for identifying patients with hemodynamically 
significant mitral regurgitation. 
1215-107 Cardioversion for Atrial Arrhythmias Can Improve Severe 
Mitral or Tricuspid Regurgitation 
Katherine Chiu, Craig R. Asher, Mark J. Niebauer, Andrea Natale, Richard A. Grimm, 
Mina K. Chung. The Cleveland Clinic Foundation, Cleveland, OH 
Although atrial fibrillation (AF) can be associated with mitral or tricuspid regurgitation 
(MR, TR), cardioversion (CV)has not be established as an effective treatment that can 
improve MR or TR, particularly if the MR or TR is severe. Methods: To determine if CV 
for persistent AF might itiprove severe MR or TR, we studied patients undergoing CV 
who had ethos within 6 mos pre- and post-CV. Changes in MR, TR, LVEF, and atrial size 
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were analyzed using ANOVA and paired T tests. Results: After 375 successful CVs, 
ethos were obtained 60t58 days after CV. Mean MR grade (O-4+) significantly improved 
from 1.38 to 1.26 (p=O.O3). Improvement of >/=2 MR grades was see” in 8.9% and in >/ 
=I grade in 29.2% of patients. TR grade improved.from 1.41 to 1.26 (p=O.O3). Improve- 
ment of >/q/=2 TR grades was see” in 11.7% and of >/=I grade in 35.0% of patients. LV 
function score improved from 1.28 to 1 .ll (p=O.O07) with mea” LVEF increasing from 
43.2 to 44.4% (p=O.O7). LA size score tended to decrease (p=O.O6), although LA diame- 
ter and areas were not significantly changed. RA area changed from 23+5 to 25*5 cm2 
(p=O.O25). Larger baseline atrial sizes ware predictive of greater improvements in LA and 
RA size after CV (p<O.O5). Also, worse severity of baseline MR and TR predicted greater 
improvements in MR (p<O.OOl) and TR (pcO.OOl), respectrvely. Improvement in TR was 
associated with decrease in RA size (p=.O27), but improvement in MR was not associ- 
ated with changes in LA size over the follow-up period. Conclusions: Improvements in 
MR and TR occur after CV and were most marked with severe MR or TR. This may justify 
attempts of CV in patients with AF and severe valve regurgitation eve” prior to consider- 
ing surgical intervention. 
1215-108 Changes in Left Ventricular Size and Hemodynamics Are 
Seen Early After Mitral Valve Repair in Patients With Mitral 
Regurgitation and Normal Systolic Function 
Syed A. Hasan, Oipan J. Shah, Deborah L. Ekery, Angie E. We”, Andrew J. Hamilton, 
David A. Fullerton, Robert 0. Bonow, Vera H. Rigolin. Northwestern University Medical 
School, Chicago, IL 
Background: Mitral valve repair is widely accepted as the treatment of choice for most 
patients with chronic mitral regurgitation (MR). Although previous studies have shown 
improvement in indices of left ventricular (LV) size and hemodynamics after valve repair, 
limited information is available on the time course of these changes. 
Methods: We examined 9 patients who underwent mitral valve repair for primary MR. 
Transthoracic echocardiograms (TTE) were performed preoperatively, and post-opera- 
tively at 19*17 days, 125226 days, and 248+42 days. Left ventricular end diastolic 
(LVEDd) and end systolic (LVESd) diameters: posterior wall and interventricular septal 
thickness; and left atrial (LA) size were measured. Left ventricular end diastolic (LVEDV) 
and end systolic (IVES/) volumes were measured using a” average of the disc summa- 
tron method in the apical two and four chamber views. Left ventricular mass was also 
calculated. 
Results: N = 9 patients. 
Baseline First Post Repair Second Post Third Post Repair 
TIE Study Repair Study Study 
LVEDV (ml) 126+31 107+42 104*35 109+37 
LVESV (ml) 47*11 43cl7 46120 41+17 
LVEF 0.62iO.07 0.59+0.11 0.56+0.08 0.63?0.04 
LA size (cm) 4.3kO.9 4.2kO.8 4.OkO.7 3.8*0.5 
LVEDd (cm) 5.5*0.5 4.9+0.6 5.0*0.6 5.0?0.6 
LVESd (cm) 3.3tO.6 3.220.8 3.3r0.5 3.2r0.5 
LV Mass(g) 256+69 233ilOO 212zt82 209+77 
Conclusion: While the decline in LV volumes and diameters occurred by the first post- 
operative study, LV mass and LA srze decreased progressively over several months. I” 
patients with normal LV systolic function and chronic MR, changes in LV chamber sizes 
and hemodynamics may be due to volume overload alone rather than ventricular remod- 
eling, thereby accounting for their rapid correction after mitral valve repair. 
1215109 Advanced Age Is Not a Contraindication to Mitral Valve 
Repair 
Richard Lee, Thoralf M. Sundt, Ill, Yi Zhang, Marc R. Moon, Michael K. Pasque, Hendrick 
B. Earner, Ralph J. Damiano, Jr., William A. Gay. Washington University School of 
Medicine, Division of Cardiothoracic Surgq Sainf Louis, MO 
Background: The clinical challenge of managing severe mitral regurgitation in the eld- 
erly is met with increasing frequency. With the aim of determining the candidacy of the 
aged for reparative surgery of the mitral valve, we retrospectively reviewed our experi- 
ence with mitral valve repair (MVRep) + or-concomitant coronary artery bypass (CAB). 
Methods: Between January 1996 and April 2000, 140 patients, 44 of whom ware aged 
70 years or greater, underwent MVRep at our institution. Risk factors for operative mor- 
tality and morbidity were analyzed. 
Results: There were 78 me” and 62 women aged 27 to 91 years (mean 62 el3) who 
underwent isolated MVRep (n=61), MVRep + CAB (n=71), or MVRep + other concomi- 
tant procedures (n=8). Camorbidities included: hypertension 57.1%, diabetes mellitus 
19.3%, peripheral vascular disease iO%, and history of stroke 10%. Of the 9 (6.4%) 
perioperative deaths, “one was after isolated MVRep. The incidence of perioperative 
renal dysfunction was 8.6%, postoperative stroke 3.6% and low cardiac output 14.3%. 
Multivariable analysis showed preoperative intraaortic balloon support (p=O.O2), preoper- 
ative renal dysfunction (p=O.O2) and non-elective surgical status (p=O.OOZ), but not age, 
as risk factors for perioperative death. Analysis for operative complications among 
patients stratified by age >= or < 70 years showd differences in atrial fibrillation (47.7% 
vs. 29.2%, p= 0.03, Pearson Chi-square), prolonged ventilation (31.8% vs. 15.6%, p= 
0.03, Pearson Chr-square) and length of hospital stay (median 9.5, range 5 -285 vs. 
median 6.5, range 2 - 36, pcO.001, MannWhItney U). There was no difference in 30.day 
readmission (15.9% vs. 22.9%) or operative death (5.2%vs.9.1%, p = 0.49). 
Conclusion: Though there is a trend toward higher operative mortality for MVRep in 
patients >= 70 years old, age alone is not a” independent predictor of outcome. No 
operative death occurred in the isolated MVRep in the aged. However, the incidence of 
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postoperative atrial fibrillation, prolonged ventilation, and greater LOS were somewhat 
higher for the aged. MVRep should not be withheld from the elderly based solely on 
age Operative candidates should undergo surgery electively if possible. 
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1248-103 The Determinants of Vena Contracta and Its Value in 
Evaluating Severity of Aortic Regurgitation 
Mehmet Eren, Bahadir Dagdeviren, Osman Bolca, Abdurrahman Eksik, Yekta Gurlertop, 
Tuna Tezel. Siyami Ersek Jhoracic and Cardiovascular Surgery Center, Istanbul, Turkey 
Background: Recent studies evaluating the severity of valvular insufficiencies have 
focus on effective orifice area (EOA). This area corresponds hydrodynamically to the 
cross-sectional area of the vena contracta (VC), the smallest cross-sectional area of the 
regurgitant flow stream. The aim of the present study was to quantify the aortic regurgita- 
tion (AR) by using the color Doppler imaged VC. 
Methods: The fifty five patients with chronic AR were enrolled in the study. VC was visu- 
alized by transthoracic echo from the apical echo window. Quantitative Doppler (QD) 
method depending on mitral (SV,) and aortic stroke volumes (SV,,) was taken as refer- 
ence method. EOA, regurgitant volume (RV) and regurgitant fraction (RF) were calcu- 
lated by using both VC and QD simultaneously in all patients. By using VC; EOA, RV and 
RF were calculated as follows: EOA,,q= (VC)’ x n/4, RV,,o= EOA,,, x VTI,” and RF,,p= 
RVv@&,. The same parameters were obtained by QD method as: RVQb= (SV,,)- 
(SV,), RFep= (RV,$V,,) x 100 and EOAoo= RVobNTIA”. The relationships between 
VC and patients parameters were evaluated by using simple linear regression analysis. 
To find the determinants of VC, multivariate analysis was performed with the parameters 
having significant correlations. 
RESULTS: EO& (r=O.96), RF a” (r=0.84), RVciD (r=0.82), angiographically Ill/IV 
degree AR (rz0.74) patient age (r=-0.67), and left ventricle end-diastolic diameter 
(r=O.47) had statistically significant correlations with VC (0.48+0.12 cm). As the result of 
the multivariate analysis with these parameters, VC was found to be related with only 
EOAO” The EOA (r=O.96, p<O.OOl; mean difference O&O3 cm’, SEE=0.004 and 
p>O.O5), RV (rz0.97, pcO.001; mean difference =1.3+4.8 cm3, SEE=0.85 cm3 and 
~~0.05) and RF (r=0.93, pcO.001; mea” difference =1.46+4.9- %, SEE=0.66 % and 
paO.05) obtained by both methods agreed well with each other. VC had a sensitivity of 60 
%, specificity of 86 % and accuracy of 84 % in determining severe AR when the lower 
limit was taken as 0.54 cm. 
CONCLUSION: VC obtained by color Doppler is a simple and reliable noninvasive 
parameter for evaluating severity of AR. 
1248-104 Influence of Loading Conditions on Physical Determinants 
of Aortic Regurgitant Flow Volume and Severity: A Chronic 
Animal Experiment 
Hiroyuki Tsujino, Michael Jones, Takahiro Shiota, YongJin Kim, Fabrice Bauer, Jian Xin 
Qin, Marta Sitges, Lrsa A. Cardon, Arthur D. Zetts, James D. Thomas. The C/eve/and 
Clinic Foundation, Cleveland, Of-/, The National institutes of Health, Bethesda, MD 
Aim: To determine the effect of different loading conditions on determinants of aortic 
regurgitation (AR). 
Methods: Chronic AR was surgically created in 8 sheep by incising one of the coronary 
cusps. After baseline studies, angiotensin II (angio), and “itroprusside (nitro) ware used 
to change the loading conditions. Electromagnetic (EM) flowmeters were used as refer- 
ence standards to determine forward stroke volumes (SV) and AR volumes (RV). CW 
Doppler was performed to obtain the velocity-time integral (VTI) and the regurgitant ori- 
fice area (ROA) by RV/VTI. To investigate the independent contribution of ROA and VTI 
on RV, RV was expressed as ROA(l+A)xVTl(l+A), where A is the relative change vs. the 
baseline. 
Results: As expected, simple regression analysis showed a reasonable correlation 
between RV and ROA (r=O.74) or VTI (r=O.63) including all sheep and all stages. How- 
ever. ROA and VTI showed different responses to the alternation of hemodvnamic condi- 
tions for each stage. (Table) 
HR AoP LVEDP SV (ml) RV ROA VTI (cm) 
@PM) @mHg) (mmH9) (ml) (mm2) 
Base 107*17 79tl8 9*3 43+14 2118 16~5 127t.22 
Angio 103*15’* 101?23* 11 r3** 48*14** 24k.8’ 1615 147*20* 
Nitro 100+21 50rl7’ 7+2* 35*13* 14*6’ 15*5 96+34** 
* p<o.o1, ** ~~0.05 vs. baseline. 
During angio infusion, %A for ROA and VTI were 0 and 15%, respectively, and resulted I” 
the RV increase by 15%. During “itro infusion, ROA remarried relatively unchanged (%A= 
-7%) but the VTI decreased by 24% and resulted in the RV decrease of 32%. 
Conclusion: In AR, ROA remains relatively constant during different loading conditions. 
VTI, which is determined by the transaortic pressure gradient, is the primary determinant 
of the change in AR volume. This should be considered when evaluating AR or reducing 
its severity by altering loading conditions. 
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1248-105 Natural History of Left Ventricular Function and Size in erative measure of EF. Patients with markedly reduced function (EF<35%, group A, 
Asymptomatic Patients With Chronic Severe Aortic n=43) were compared to those with moderate reduction in EF (EF 35 to <50%, group B, 
Regurgitation and Initially Normal Resting Function: n=134) and to those with normal function (EF>50%, group C, ~273). There was no dif- 
Relation of Temporal Patterns to Adverse Cardiac Outcome ference in other baseline characteristics between the 3 groups (Table). Results: Patients 
with EF<35% (group A) had higher operative mortality compared to group B and C (14% 
Phyllis G. Supino, Jeffrey S. Borer, Claw A. Hochreiter, Edmund M. Herrold, Richard B. 
Devereux, Mary J. Roman, Paul Kligfield, Andrew Yin. Weill Medical College of Cornell 
Universifl: New York, NY 
Background: Among asymptomatic pts with aortic regurgitation and nl LV ejection frac- 
tion(EF) at rest(r), the EF at peak exercise(w) and the change(A) from I to ex are highly 
useful in predicting imminence of heart failure, subnl LVEF, and /or sudden death. How- 
ever, the appropriate inter-test interval to detect the “high risk” AEF and EFex predictors is 
unclear and the implications of progression rates of AEF and EFe. are unknown. Meth- 
ods: Among 90 asymptomatic pts with chronic severe aortic regurgitation and nl EF, at 
study entry, we determined rates of change in radionuclide cineangiographic EF and 
echocardiographic LV internal dimensions(lD) during 7?6, yr annual study and related EF 
and ID change regression slopes to outcome. Results 
Average Group Change/Yr Maximal Individual Changer(r 
LVEF, -0.12*1.18% -6.47% 
LVEF, -0.71 + 1.97% -9.71% 
A L”E%to ex, -0.61 ? 1.58% -7.87% 
LVlDdiastole 0.09 + 0.21 cm 1.06 cm 
“High risK’ AEF (AEF< -5%,12 pts) and absolute subnl EF, [3pts] developed in 15/90 
(16.7%) pts during 1 yr follow-up; 13115 pts remained symptom-free. Temporal deteriora- 
tion in EF, was best predicted by poor baseline AEF at study entry(p=.OOl). Endpoints 
occurred in 27190 pts during follow-up (sudden death[3 pts], symptoms i subnl EF,[19 
pts], subnl EF, alone[5 pts]). Endpoints were associated with a greater than .32%/yr dete- 
rioration of EF ,(p=.OOOS, 21 endpoints in 44[48%] pts) and with a greater than .19%/yr 
deterioration of AEF(p=.Ol), but not by change rate of EF, or echo LVID (all NS) over 
time. Conclusions: Though AEF deteriorates more rapidly than EFr both generally 
change relatively slowly over time. Nonetheless, the rapid rate of change in some pts, 
and the predictive value for adverse outcomes inferable from measured rate of change in 
AEF and EF,,, mandate periodic observation even in asymptomatic pts to identify rapid 
change rates as well as development of “high risk” descriptors. The maximal rate of EF 
change and frequency of new “high risk” descriptor development suggest an inter-test 
interval of approximately 1 yr for optimal detection of prognostically important variations 
preceding clinical events. 
vs 7% vs 4% respectively) (~~0.04). At 10 years, group A patients had survival of 41?9% 
compared to 56+5% and 70*3% for group B and group C respectively (pcO.0001). The 
adjusted hazard ratio of group A vs C was 1.94 [95%CI=i .2-3.11. The lo-year rate of 
heart failure in group-A patients was 25% vs. 17% and 9% in groups B and C respec- 
tively (p-zO.003). Thromboembolism was not different between the 3 groups. Postopera- 
tive Ejection fraction improved by 4.9c2.5%(p c 0.06) and by 4*1.2%(p=O.O02) in group 
A and B patients vs. a decline of 2.3+0.8(p=O.O05) in group C. 
Group A-EF < Group B-EF 35. Group C- P value 
35% 50% EF>50% 
Age (YES) 58*14 58+16 56~15 NS 
Ejection fraction (%) 28 k 5 59+6 43s5 <0.002 
%women 19 23 22 NS 
Prior CABG (%) 21 22 23 NS 
Conclusions: After surgical correction of severe AR, 1) patients with reduced EF incur 
an excess operative mortality, late mortality and heart failure rate and therefore AVR for 
AR should be performed preferably at an earlier stage. However, among patients with 
severe preoperative EF reduction, 2) after AVR, EF significantly and markedly improves 
and 3) the majority of patients enjoy a long postoperative survival without recurrence of 
heart failure. Thus, these patients should not be denied the benefits of AVR. 
1248-106 Decreased Contractile Reserve in Severe Aortic 
Insufficiency Using MRI-Derived Stress and Strain 
Relationships 
Giridhar Vedala, Pavlos Moustakidis, Randall P Scheri, Brian P Cupps, Robert J. 
Gropler, Nancy J. Nickerson, Nicholas T. Kouchoukos, Michael K. Pasque, Victor G. 
Davila-Roman. Washington University School of Medicine, St. Louis, MO 
The timing of aortic valve surgery in patients with significant aortic insufficiency (Al) can 
be difficult. Many indices of myocardial contractile performance are load-dependent and/ 
or require assumptions in left ventricular (LV) geometry. We propose to measure load- 
independent indices of LV contractility which do not require geometric assumptions. LV 
end-systolic stress (LVESS) and LV strain relationships were measured “sing magnetic 
resonance imaging (MRI). Methods: 7 patients with significant Al (6 male, 48+17yrs.) 
and normal LV function, scheduled to undergo aortic valve surgery, and 15 normal volun- 
teers (N) (7 male, 45+22yrs.) underwent MRI at rest and during inotropic stimulation 
(dobutamine, iOpg/kg/min). Al patients had no significant coronary atherosclerosis by 
cardiac catheterization. All healthy volunteers had normal restistress echocardiograms. 
Midventricular, short-axis MR images were used for all analyses. P-dimensional (2D) 
LVESS was measured “sing finite element analysis. Pressures were obtained from cali- 
brated noninvasive Millar carotid artery tracings. 2D LV strains were obtained by measur- 
ing deformation of splines superimposed on MRI tag lines. Results: Fractional area 
change and LVESS were similar between the Al group and the N group (43 f 6% vs. 48 * 
7% 15.0x104+ 3.0~10~ vs. 12.6x104i 2.6~10~ dynes/cm’, respectively, p =NS for both). 
LV strain at rest was significantly lower in the Al group (2.0x10-‘+ 4.0x10” vs. 2.5x10-‘* 
3.2x10w’, pcO.01). At rest, the strain / stress ratio was significantly reduced in the Al 
group compared with the N group (1.36x1U6+ 3.4x10-’ vs. 2.1~10’~~ 5.3x10-’ cm’/ 
dynes, p<O.Ol, see figure). This ratio did not increase with inotropic stimulation in the Al 
group (1.45~10-~f4.6~10’~, p=NS vs. rest), compared to the N group (2.7~10.“i- 52x10. 
7z pcO.01 vs. rest, see figure). Conclusions: Patients with significant Al have diminished 
contractile reserve, assessed by MRI-derived strain/stress relationship. This is a noninva- 
sive, load-independent index that does not require geometric assumptions. This method 
may uncover subclinical myocardial dysfunction, and may be useful in determining the 
optimal time for surgery. 
1248-107 Outcomes FOlIowing Aortic Valve Replacement in Patients 
With Severe Aortic Regurgitation and Markedly Reduced 
Ejection Fraction 
Had P Chaliki, Dania Mohty, Jean francois Avierinos, Hartzell V. Schaff, Maurice E. 
Sarano. Mayo Clinic, Rochester, MN 
Background: Left ventricular dysfunction is an indication for aortic valve replacement 
(AVR) in severe aortic regurgitation (AR). However, the post-operative outcome of 
patients with severe AR and markedly reduced ejection fraction (EF) is not known. There- 
fore, it is unclear whether these patients should undergo AVR or if other types of interven- 
tion should be considered. Methods: Among 500 patients who underwent surgery for 
isolated severe AR between 1980 and 1995, we analyzed 450 patients who had a preop- 
1248-108 Very Long-Term Outcomes of Aortic Valve Replacement 
With Mechanical Versus Tissue Aortic Valve Prosthesis in 
Young Patients 
Dania Mohty, Jean Francois Avierinos, Richard C. Daly, Maurice E. Sarano. Mayo dinic, 
Rochesfer, MN 
Background: Aortic Regurgitation (AR) is observed often in young patients (>55yrs). 
However, the best substitute (mechanical or tissue (xenograft or homograft) prosthesis 
for aortic valve replacement (AVR) in this population is unknown because the very long- 
term post-operative outcome of these patients has not been reported. Methods and 
results: From 1980 to 1995, 196 patients aged ~55 yrs underwent AVR for severe AR 
(131 with mechanical prostheses (MP) and 65 with tissue prostheses (TP)). Results: 
Baselines characteristics were not significantly different in MP vs. TP (mean age: 42111 
vs. 40~10; % men 89% vs.83%; mean ejection fraction 52~12 vs. 52&12; % NYHA class 
Ill-IV: 25% vs. 26%; % with associated bypass grafting: 9.9% vs.7.7%; all P>O.O5). Oper- 
ative mortality was respectively 1.5 and 3% (p=O.40). Long-term post-operative outcome 
compared in MP and TP is shown in Table. There was no difference between the out- 
comes of xenografts and homografts (all P20.26). Conclusion: In patients younger than 
55 years old who require AVR for severe AR, the very long-term outcome of mechanical 
prostheses compared to tissue prostheses shows 1) a slight excess thromboembolic or 
hemorrhagic events but 2) an excellent long-term survival and a low rate of heart failure. 
3) Homografts do not appear superior to xenografts in that indication. 4) Mechanical 
prostheses provide better survival and freedom from heart failure than tissue prostheses 
and avoid their considerable rate of reoperation. 5) Therefore, mechanical prostheses 
should be the preferred approach to AVR for AR in the patients<55 and represent a refer- 
ence for future attempts at tissue replacement or conservative surgery. 
15 years outcome Survival Reoperation Heart Failure Embolism or hemorrhage 
MP 76 r 5% 20 k 5% 11 * 3% 32 f 5% 
TP 58 f: 8% 86 +I 1% 28 + 8% 18+6% 
P value 0.05 < 0.0001 0.01 0.05 
1248-109 A Novel Aortic Root Prosthesis With Compliant Sinuses For 
Valve Sparing Operations 
Mano J. Thubrikar, Francis Fiobicsek, Kenton J. Zehr*, Eric Skipper, Geoffrey G. Gong, 
Brett L. Fowler.. Heineman Research Laboraforx Dept. of Cardiovascular Surgery, 
Carolinas Medical Cenfer, Char/me, NC, *Mayo Clinic, Div. of Cardiovascular Surgery, 
Rochester, MN 
Introduction: Our goal is to design a new aortic root prosthesis with compliant sinuses, 
test it in vitro and then “se in patients for the valve sparing operation. Methods: The 
ascending aorta portion of the prosthesis was made by scalloping one end of the tubular 
dacron graft. The three s~n”s?s were made individually after turning the z-folds in the fab- 
ric 90? A rectangular piece was cut and two purse strings were sewn to form the sinus, 
which was then sutured to the scalloped tube. In vitro, in 8 human aortic roots of 17-21 
mm sine-tubular junction diameter, the aortic wall was trimmed 2 mm above the commis- 
sures and scalloped parallel to the leaflet attachment. The graft was sutured to the scal- 
loped valve. The aortic graft root was studied in a left heart simulator at 80140 to 150/100 
mmHg pressure and 4tImin CO. The leaflet movement was video-recorded at 500 
frames&c. The commissural movement was measured with intravascular ultrasound. 
The geometry of the graft root was determined from a silicone rubber mold. Seven intact 
aortic roots were also studied. The prosthesis was used in 4 patients with annuloaortic 
ectasia and trivial to severe Al. Their aortic root was reconstructed with the prosthesis 
and the valve was spared while on cardio-pulmonary bypass. Results: In vitro, in the aor- 
tic graft roots, the valves were competent and had no valvular gradient. The valve opened 
to a circular orifice and the leaflets did not touch the graft The commissural diameter 
increased by 24% (25% in the intact root) when the pressure increased from 0 to 80 
mmHg and further by 6% (7% in the intact root) when the pressure increased to 120 
mmHg. The sinuses had a tear drop shape and bulged outward. In all patients, postoper- 
atively, the geometry of the normal root was restored with a near normal aortic valve 
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function and none to mild Al. Conclusions: The dynamics of the valve leaflets in the aor- Conclusion: Cardiac ACE activity is independent from ACE gen polymorphism, 
tic root prosthesis were comparable to that in the natural aortic root. The use of the novel increases parallel to ventricular hypertrophy and diastolic left ventricular dysfunction and 
prosthesis for aoriic root reconstruction and valve sparing was successlul in patients. decreases parallel to impaired systolic function. 
ORAL CONTRIBUTIONS 
875 Nlolecular and Cellular Alterations in 
Chronic Valvular Regurgitation 
Tuesday, March 20, 2001, 4:00 p.m.-500 p.m. 
Orange County Convention Center, Room 414A 
4:00 p.m. 
875-i Elevated Glycosaminoglycan Content of Myxomatous Mitral 
Valves Is More Severe in Unileaflet Than in Bileaflet 
Prolapse 
875-3 
4:30 p.m. 
Increased Fibronectin Expression in Aortic Regurgitation: 
Role of Stress Activated Protein Kinasek-Jun NH,-Terminal 
Kinase Pathway 
Sharada L. Truter, Jennifer A. Lee, Thsmy F. Dumlao, Jr., Jeffrey S. Borer. We;// Medical 
College of Cornell University, New Vork, NY 
Kathryn J. Grand&Allen, Brian P Grifhn, William R. Mills, Norman B. Ratliff, Delos M. 
Cosgrove, III, Ivan Vesely. Cleveland Clinic Foundation, Cleveland, OH 
Background: Myxomatous mitral valve disease may lead to either unileaflet prolapse 
(ULP) or bileaflet prolapse (BLP), which is more difficult to repair surgically. Recent 
echocardiographic and mechanical data suggest that chordae in ULP are actually more 
mechanically compromised than chordae from valves with BLP. In order to determine a 
biochemical basis for these differences, our study compared the content of water, col- 
lagen, total glycosaminoglycans (GAGS), and specific GAG classes of valves with ULP 
and BLP. Methods: Myxomatous mitral valves (n=45 ULP, 9 BLP) were obtained from 
pathology immediately following surgical resection. Control valves (n=lZ) were obtalned 
from autopsy. Posterior leaflets and chordae were solubilized with a serine protease then 
assayed for collagen concentration (hydroxyproline) and total GAG concentration (hexu- 
ronic acid). Fluorophore-assisted carbohydrate electrophoresis (FACE) was used to ana- 
lyze the specific GAG classes. Aliquots of the sample solutions were further digested 
using enzymes for specific GAGS at 37°C for at least 3 hours, then fluorotagged at 37°C 
for 16 hours. The samples ware electrophoresed for 75 minutes and the gels imaged to 
quantify the specific GAG bands. Results and Conclusions: (1) Collagen content was 
not significantly different between the control, ULP. and BLP leaflets or chordae. (2) Both 
BLP and ULP result in greater GAG and water content as compared to controls. (3) 
Chordae in ULP have significantly greater GAG content that can be attributed to a selec- 
tive increase in chondroitin/dermatan 6-sulfate. These GAGS are associated with extra- 
cellular matrix structure, particularly the hydration-related sponginess of the tissue. 
These abnormalities may explain the reported mechanical weakness and greater inci- 
dence of flail in ULP. 
Background: We have previously shown that chronic aortic regurgitation (AR) causes 
myocardial fibrosis featuring selective upregulation of fibronectin (FN) gene expression 
with abnormally FN-rich extracellular matrix, and that this finding is reproduced by normal 
(nl) cardiac fibroblasts (CF) exposed in culture to AR-like mechanical strain. Thus, FN 
upregulation (and fibrosis) may be mediated directly by the mechanical stresses of AR. 
We hypothesize that stress transduction involves the stress-activated protein kinase/c- 
Jun NH*-terminal kinase pathway (SAPKIJNK) since, in other systems, ATFPic-Jun 
complexes bind to the FN promoter to induce FN transcription. To test this hypothesis, we 
assessed JNK activity in AR and nl CF. Methods: Triplicate CF cultures from 3 paired nl 
and surgically-induced AR NZW rabbit hearts (R fractions(F)=l4%, 25% and 38%) were 
lysed in NP-40-based buffer containing protease inhibitors and were centrifuged. Homo- 
genate aliquots were incubated in kinase buffer with 2.5uCi 3zP-uATP and 2.5ug GST-c- 
Jun.I. Samples were separated by SDS-PAGE. Gels were dried and exposed to X-ray 
film. Relative phosphorylation of c-Jut- by JNKl was assessed by videodensitometry of 
bands corresponding to 3”P-labeled GST-c-Jun.1. Results: JNKl activity (AR:nl) was 
1.4:1 and 2.0:1 for AR-RF=25% and 38%, respectively, and decreased minimally (0.7:l) 
for AR-RF=14%; thus, a strong linear relation was observed between JNK activity and 
AR-RF (&.99, pc.06). Conclusion: Chronic severe AR stimulates JNKl activity, sug- 
gesting activation of the SAPWJNK pathway in transducing mechanical stress to abnor- 
mal fibrosis in AR. Further study must define the remainder of the stress transduction 
pathway and must test the effects of its blockade. 
875-4 
4:45 p.m. 
Remodeling of the Cardiac Extracellular Matrix Differs 
Between Volume and Pressure Overloaded Ventricles and Is 
Specific for Each Heart Valve Lesion 
Corn& Piper, Dieter Horstkotte, Daniel Akdemir, Joern Rudolf, Heinz-Peter Schultheiss, 
Matthias Pauschinger. Heart Center North Rhine-Wesiphalia, Bad Oeynhaosen, 
Germany, University Hospital Benjamin Franklin, Berlin, Germany 
Collagen and GAGS in leaflets (L) and chordae (C). * p<O.O5 vs. control, t pcO.05 
ULP vs. BLP 
Control ULP BLP 
L: collagen, % of dry weight 55.1k8.7 56.6t14.2 60.4+19.3 
C: collagen, % of dry Weight 63.8C9.4 65.Ok14.3 63.4115.1 
L: total GAGS, mgig wet weight 4152265 7061-364 * 680+316 * 
C: total GAGS, mgig wet weight 6545342 1242*640 * 1056+358 * 
L. chondroitinldermatan 6.sulfate, nmollg 813&38 1484+651 * 1481i772 * 
6: chondroitinldermatan 6.sulfate, nmollg 900+466 1688*977 *t 972i-406 
875-2 
4:15 p.m. 
Cardiac Angiotensin Converting Enzyme Activity and ACE 
Gen Polymorphism in Patients With Chronic Valvular 
Disease 
Cornelia Piper, 0. Costerousse, M. Schmidt, Dieter Horstkotte. Heart Center North 
Rhine-Westphalia, Bad Oeynhausen, Germany 
Background: The renin-angiotensin-system (RAS) induces cardiac hypertrophy and 
influences cardiac function. As there is evidence for a local cardiac RAS, we analyzed 
whether cardiac ACE activity can be measured in small myocardial biopsies and whether 
it is correlated to the severity of ventricular hypertrophy induced by chronic volume or 
pressure overload due to valvular heart disease (VHD). 
Methods: We could establish a very sensitive and specific enzymatic assay using high- 
speed liquid ChrOmatOQraphy (HPLC) for quantification of ACE activity. The biopsies were 
taken from the interventricular septum (IVS) of 19 patients (P) with moderate to severe 
aorlic stenosis (AS), 18 P with aortic (AR, n=8) or mitral regurgitation (MR, n=lO). In 
addition, endomyocardial tissue (IVS) from explanted hearts (EXPL) of 12 P with end- 
stage heart failure (HF) due to ischemic or dilated cardiomyopathy were examined. The 
ACE-genotype of P with VHD was determined by PCR technique. 
Results: The average level of ACE activity in AS (3.0+1.2mU/mg protein) was not differ- 
ent from that in AR ( 4.2+2.2) or in MR (3.7+1.3). but from that in EXPL 
(1.6+0.9)(p=O.O005). ACE activity was reduced in VHD if systolic function (cardiac index. 
I= -0.24) was impaired or maximum oxygen uptake (r= -0.26) reduced, but increased par- 
allel to parameters indicating diastolic dysfunction (e.g. LVEDP: I’= +O.Zl) and to lefl ven- 
tricular hypertrophy (left ventricular mass index: I= +0.34, p=O.O38). ACE activity 
decreased parallel to the transaortic pressure loss(r= -0.46, p=O.O46) in AS, but not to 
the transvalvar regurgitation fraction. The underlying ACE-genotype did not influence the 
ACE activity. 
Background. Chronic pressure overload induces concentric, volume overload eccentric 
left ventricular hypertrophy. Consequently, different patterns of fibroblast-mediated 
remodeling of extracellular matrix (EM) might be expected in patients (P) with pressure or 
volume induced left ventricular hypertrophy. 
Methods. EM was analyzed in 38 P with chronic pressure overload due to aortic stenosis 
(AS, n=19) and with chronic volume overload (aortic regurgitation (AR), n=9, primary 
mitral regurgitation (MR). n=lO). Biopsies from IO P with moderate dilated cardiomyopa- 
thy served as controls (C)The amount of interstitial cardiac collagen, of thick (red/yellow) 
and thin (green) collagen fibrlls were quantified computer-assistedusing circular polariza- 
tion in picrosirius red stained endomyocardial biopies. In addition, collagen-type-l (Coil-I) 
and collagen-type-Ill (Co&Ill) gene expression was evaluated by polymerase chain reac- 
tion (qRT-PCR) and procollagen-l/procollagen-Ill ratio and density of fibroblasts (FBI 
vision-field) were analyzed afterimmunhistological stainlngs. 
Results. The amount of interstitial cardiac fibrosis (ICF) was significantly higher in P with 
AS (5.7c4.lg/m2), AR (8.8+4.9g/m*) and MR (4.7&8g1m2) than in C (2.3il.5gim2) 
(p=O.O03). The amount of thick collagen fibrils was higher in AR (8.2+5.2g/m2) than in AS 
(5.3*3.6g/mz), while density of fibroblasts did not differ (AR,FB:12+3; AS,FB:12+5). In 
volume overloaded ventricles Coil-l/Coil-Ill ratio shifted towards Coil-I on both mRNA and 
protein levels, in pressure overloaded towards Coil-Ill. The severity of EM remodeling 
was positively correlated with endsystolic wall stress and impaired diastolic function but 
neither with systolic function nor clinical symptoms. 
Conclusion. Remodeling of EM is specific for left ventricular volume and pressure over- 
load and is an early indicator for inadequate adaptation to chronic overload due to heart 
valve lesions. 
POSTER SESSION 
1281 Mitral Valvuloplasty 
Wednesday, March 21, 2001, 9:00 a.m.-l I:00 a.m. 
Orange County Convention Center, Hall A4 
Presentation Hour: IO:00 a.m.-l I:00 a.m. 
1281-l 03 The Use of Mitral Valve Resistance in the Evaluation of 
Native Mitral Valve Stenosis 
Carey L. O’Bryan, IV, Daniel S. White, Steven Guidera, Robert M. Saad. Wilfofd Hall U.S. 
Air Force Medical Center, San Antonio. TX 
Background: Measurements of valve area and valve resistance can be used to assess 
the severity of stenotic valves. Gorlin-derived valve areas vary with flow to a much 
greater degree than resistance measurements. There are few data on mitral valve resls- 
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tance (M/R) in cases of mitral stenosis (MS). We sought to determine if MVR could be 
reliably calculated from transthoracic echocardiography (TTE) in cases of native MS, and 
to define the range of normal values for MVR. 
Methods: The invasive hemodynamics and TTEs of 19 patients with mrtral stenosis who 
underwent cardiac catheterization and percutaneous balloon mitral valvuloplasty (PBMV) 
at our institution between July 1995 and June 1998 were reviewed retrospectively. We 
also reviewed 19 TTEs from age-matched patrents with normal hearts. All patients with 
mitral stenosis underwent a complete TTE and right and left heart catheterization before 
and after PBMV. Patients with greater than mild mitral regurgitation, intracardiac shunt, 
coincident aortic stenosis or greater than mild aortic insufficiency were excluded. 
Results: MVR derived by cardiac catheterization varied inversely and exponentially with 
Gorlin-derived mitral valve area ( p<O.OOOOi) and demonstrated a linear relationship to 
MVR obtained by TTE (r~O.81; p<O.OOOOi). Furthermore, mitral valve area determined 
by the continuity equation varied inversely and exponentially with MVR obtained by TTE 
(p<0.00001). When stratified according to disease severity, a MVR>89 dynesecicm5 
identified all patients with severe MS. The values of MVR for patients with normal hearts 
ranged from 5-16 dyne.sec/ch+ with a mean of 8 dyne.sec/cma. 
Conclusion: To our knowledge, this is the first study to demonstrate that MVR can be 
reliably assessed by TTE, and the first to define the normal range of MVR. The results of 
this study suggest that a MVR>89 dyrwsecicme is another marker of severe MS and 
may have clinical utility. 
1281-104 C-Reactive Protein Elevation Is Common in Rheumatic 
Mitral Valve Stenosis and Inversely Correlates With Success 
of Percutaneous Balloon Mitral Valve Commissurotomy 
Richard A. Krasuski, Charles E. Mayes, John J. Warner, Andrew Wang, Katherine Kisslo, 
Cynthia Pierce, Karen Pieper, J. Kevin Harrison, Thomas M. Bashore. Duke University 
Medical Center, Durham, NC 
Background: Rheumatic mitral stenosis is believed to be the sequela of earlier strepto- 
coccal infection. Whether chronic systemic inflammation is present in these patients and 
its impact on treatment by percutaneous balloon mitral valve commissurotomy (PBMC) is 
unknown. 
Methods: Baseline measurements of C-Reactive Protein (CRP) by high-sensitivity assay 
were performed at the time of PBMC or during post-procedural follow-up in 95 patients 
with mitral stenosis of rheumatic morphology by clinical echocardiography. Patients were 
carefully questioned to exclude recent infections and inflammatory conditions. Patients 
were categorized into three groups according to CRP levels: undetectable, within normal 
assay range (less than 0.6 mg/L) and elevated (1 0.6 mg/L). PBMC Procedural success 
was defined by a final mitral valve area (MVA) 11.5 cm* or > 50% increase in mitral valve 
area, no more than 2+ mitral regurgitation (MR) and an intra-atria.1 shunt 1.5 or less. 
Results: CRP was elevated in 35% of the patients studied (range 0.6 to 6.42 mg/L). Pro- 
cedural success occurred in 60% (21135) of patients with elevated CRP, in 70% (23/33) of 
patients with CRP within normal range and in 89% (24/27) of patients with undetectable 
CRP (p=O.OlO). Procedural success correlated (by univariate analysis) with valve score 
(p=O.O14) and CRP (~~0.066) but not age (p=O.303). There was no difference in post- 
procedural MR among the groups. Absolute CRP levels did not correlate with any partic- 
ular component of the valve score (mobility, thickening, calcification and submitral scar). 
Among the groups there was a correlation between lower CRP level and percent 
improvement in MVA with PBMC (p=O.O26). 
Conclusions: Systemic inflammation is present in more than i/3 of patients with rheu- 
matic mitral valve stenosis. The presence of increased inflammation was associated with 
less improvement in mitral valve area and gradient after balloon commisurotomy. 
PBMC Result by CRP Level 
CRP Level % ,nc,ease I” Mitral valve Area % Decrease in Mean Mitral Valve Gradient 
Elevated 59.0 +/- 41.4 % 40.4 ii- 19.8 % 
Normal 64.4 +/- 40.0 % 52.3 +/- 12.7 % 
Range 
Undetectable 82.6 +I- 35.2 % 55.0 +/- 16.3 % 
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1281-105 Acute and Follow-Up Results of Percutaneous Trans-Mitral 
Commissurotomy in 352 Patients of Juvenile Mitral Stenosis 
Dhiraj Gupta, Vinay K. Bahl, Gautam Sharma, Shyam S Kothari, Anita Saxena, Rajnish 
Juneja, Kewal C Goswami, Kewal K Talwar, Subhash C Manchanda. AN lndia lnstitufe of 
Medical Sciences, New De/hi, India 
Background: Juvenile mitral stenosis (MS) is commonly seen in the developing world. 
However, no large studied has specifically studied the factors influencing the results of 
percutaneous trans-mitral commissurotomy (PTMC) in these patients. Methods: We 
analyzed our past seven years’ experience of PTMC in juvenile MS (aged < 20 years). 
This included 352 patients (181 males) with a mean age of 15.1*2.8 years. 56 children 
were aged less than 12 years. The mean height was 152.4*13.3 cm, mean weight was 
36.9k9.7 kgs and mean body surface area (BSA) was 1.27kO.22 cm2. Follow up (FU) 
was available for 282 (80%) patients for a mean FU period of 24.3~17.7 months (l-82 
months). Results: PTMC was successful (final indexed mitral valve area, MVA > 1.0 
cm2) in 324 (92%) cases and inadequate in 28 (8%) cases. 14 (4.0%) developed severe 
mitral regurgitation (MR) (1 death). Unsuccessful PTMC was related to greater baseline 
left artial pressure (p=O.O03) and transmitral gradients (p=O.O07) but not to age, gender, 
anthropometric characteristics, balloon size ratios, left atrial size or other baseline vari- 
ables. On multivariate analysis, significant MR was related to female sex (p=O.O03, OR= 
3.2) and lesser BSA (p=O.O3). There were no differences in baseline characteristics or 
result parameters among patients in whom the balloon size equaled or exceeded the rec- 
ommended balloon size, RBS (58%) and in those in whom the balloon size was > 1 cm 
lesser than the RBS (42%). Over the FU period, 9 patients underwent mitral valve sur- 
gery, 5 because of severe MR and 4 because of inadequate PTMC. Two patients under- 
went repeat PTMC with good result. At FU echo, the mitral valve area (1.52+0.36 cm2) 
was not significantly different from that immediately post PTMC (1.57+0.51 cm2), but 
there was significant decrease in LA size (p<O.OOi) and TR velocity (p=O.Ol). Conclu- 
sions: As seen in this largest series reported in literature, PTMC has good results in 
juvenile MS. Smaller balloon sizes than recommended should be tried in these patients 
as they are equally effective. This is especially desirable in females and those with lesser 
BSA in whom the risk of developing significant MR IS greater. 
1281-106 A Prognostic Model to Predict the Disappearance of Left 
Atrial Thrombi Among Candidates for Percutaneous 
Transvenous Mitral Commissurotomy Under Oral 
Anticoagulant Therapy 
Songkwan Silaruks, Bandit Thinkhamrop, Wirote Tantikosum, Chaiyasith Wongvipaporn, 
Pyatat Tatsanavivat, Orathai Pacheerat, Virat Klungboonkrong. Srinagarind 
Hospital,Khon Kaen University, Khon Kaen, Thailand 
Background: The presence of a left atrial thrombus (LAT) in rheumatic mitral stenosis 
(MS) patients is considered as a contraindication to percutaneous transvenous mitral 
commissurotomy (PTMC). Although it is known that oral anticoagulant (OA) therapy can 
dissolve the LAT in some circumstances,and let MS patients get the benefit of PTMC, no 
study has attempted to develop a prognostic model to predict such success. Objectives: 
To develop and validate a simple tool that can be used to predict the disappearance of 
LAT among candidates for PTMC who were receiving long term OA therapy. Design: 
Prospective cohort study. SETTING: A tertiary teaching hospital in Northeastern Thai- 
land. Methods: We prospectively recruited 108 candidates for PTMC with documented 
LAT, under long term OA therapy. All patients underwent both transthoracic and transe- 
sophageal echocardiographic studies and were followed up for 34 months with a 62% 
disappearance rate of LAT. The sample was randomly divided into two subsets, 54 each, 
one to derive the model and another to validate it. The analysis was done using multiple 
logistic regression. Results: The predictive model was as follows: P = 1 / [I + Exponen- 
tial (-8.1 + l.SNYHA + 0,7AREA)], where NYHA = New York Heart Association Func- 
tional Class (scoring as 1 to 4), and AREA = area of the LAT (cm2). The model was well 
calibrated (P = 0.82 for the goodness-of-fit test) and discriminated well (area under the 
receiver operator characteristics [ROC] curves, 0.92). Performance in the validation sam- 
ple was equally good (area under the ROC curve, 0.92 and the goodness-of-fit test, 
0.16). When applied to the validating data set using the cut point of P z 0.7 for being clas- 
sified as disappearance of LAT, the model had a sensitivity of 93.3% (95%CI: 77.9% to 
99.2%) a specificity of 79.2% (95%CI: 57.8% to 99.9%) a positive predictive value of 
84.9% (95%CI: 68.1% to 94.9%) and a negative predictive value of 90.5% (95%CI: 
69.6% to 98.8%). Conclusion: Combined clinical and echocardiographic variables are 
predictive of 34.month outcome of OA therapy in resolution of LAT among candidates for 
PTMC.This simple and valid predictive model may be greatly useful as a part of a clinlcal 
assessment and proper management. 
1281-l 07 Percutaneous Mitral Valvuloplasty With lnoue Balloon 
versus Metallic Commissurotome: A Prospective 
Randomized Study 
Enio E. Guerios, Ronaldo Ft. L. Buena, Jose C. E. Tarastchuk, Deborah C. Nercolini, 
Paula M. l? Andrade, Alvaro L. A. Pacheco, Sonia Perreto. Hospital Evangelico, Curitiba, 
Brazil 
Background: The lnoue balloon catheter (IB) is the ‘“gold standard” for percutaneous 
treatment of mitral valve stenosis (MVS). A reusable metallic commissurotome (MC) with 
an ongoing international registry with more than 800 pts. enrolled has been developed 
since 1996 with the goal of improving the results and cost-effectiveness of mitral valvulo- 
plasty. To date, no randomized trial has compared these two techniques. Methods: We 
conducted a prospective, single-center randomized study in which 42 consecutive pts. 
(83,3% female) with severe MVS underwent percutaneous mitral valvuloplasty using the 
IB (n=22) or the MC (n=20) technique. Procedural success was defined as a final mitral 
valve area (MVA) >1.5 cm2 with no mitral regurgitation (MR) >2/4 (Sellers). Clinical, 
echocarciographic and hemodinamic data were compared between the groups. Results: 
The success rate was 100% in the IB vs. 95% in the MC group (p=O.17). The same MC 
was used in all of the 20 ptstreated with this device. 
IB MC P 
Age (years) 38.0~12.7 39.&l 1.4 0.33 
Left atrium (mm) 48.9+6.6 47.1k2.4 0.13 
Sinus rhythm (%) 86.4 60 0.027 
Wilkins score/l6 7.1e1.8 6.9%1.5 0.36 
MVA pre (cm2) 1.13*0.19 1.12+0.18 0.42 
gradient pre (mmHg) 12.4k3.7 9.6+3.9 0.01 
MVA post (cm2) 1.96kO.39 2.14eo.35 0.05 
MVA absolute incr. (cm2) 0.83t0.4 1.03io.3 0.05 
gradient post (mmHg) 6.2k2.2 6.1+3.3 0.48 
major complications (n) 0 3 0.03 
Major complications included 1 MR grade 314 requiring valve replacement and 2 tampon- 
nades treated in the cath lab. There was no death, no embolic event and no significant 
residual transatrial shunt in both groups. Conclusion: The MC provides a larger post-val- 
vuloplasty MVA and a greater absolute increase in MVA than the 16, and may be more 
cost-effective because permits multiple uses after sterilization. However, complication 
rate was higher in the MC group, perhaps an impact of the learning curve of the opera- 
tors. 
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1281-108 Baseline Characteristics and Results of Percutaneous 
Mechanical Mitral Commissurotomy in Adolescents and 
Young Adults 
H&l&e Eltchaninoff, Catherine Nafeh, Raphaelle Carlot, Carlos Giron, Alain Crib& foi 
the Investigators of the Multicenter Registry. Charles Nicolle Hospital, Rouen, France 
Background. The reusable metallic commissurotome has been available since 1996 for 
the percutaneous treatment of mitral stenosis and evaluated in an international registry 
(13 countries; 1098 patients). The aim of this analysis was to assess the baseline char- 
acteristics and the results of mitral commissurotomy in young adults (5 20 years) and to 
compare them to older patients (pts) > 20 years. 
Methods. We divided the entire population into 2 groups according to the age of the pts: 
5 20 years (n= 140) vs > 20 years (n= 958). Baseline clinical, echographic and hemody- 
namic characteristics, immediate results (final mitral valve area (MVA) assessed at 24 
hours by 2-D echography; complications; SUCCESS rate) were compared. Severe compli- 
cations included death, tamponade, mitral regurgitation (MR) z 2 on angiography (Sellers 
Classification) and stroke. Procedural success was defined bv a final MVA > 1.5 cm2 with 
noMR>2. 
Results 5 20 yrs > 20 yrs P 
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4P (YW 17&2(12-20) 38 it 12 (21.86) <.OOOl 
Female (%) 58% 68% .02 
Prior commissurotomy 4% 16% .oooz 
Sinus rhythm 82% 69% <.OOOl 
LA diameter (mm) 4656 49+6 <.OOOl 
Wilkins score/l 6 7.0 + 1.4 7.8ki.9 < 0.0001 
MVA (cm2) base 0.8 i 0.2 0.9 i 0.2 <.004 
Gradient (mmHg) base 2217 19i8 <.OOOl 
PAS* (mm Hg) base 66&26 56+23 <.OOOl 
Final MVA (cm2) 2.1 f 0.3 2.1 * 0.4 NS 
Final gradient (mmHg) 4+4 4+4 NS 
Success rate 95% 93% NS 
(’ PAS: pulmonary artery systolic pressure). Rate of severe complications was similar in 
both groups: tamponade (0% vs 1.4 %), severe MR (2.8% vs 2.5%), stroke (0% vs 0.2%). 
Only one (0.1%) pt died (> 20 years old). 
Conclusion. Very young pts with mitral stenosis are more often male, in sinus rhythm, 
with less distorted valve, less prior commissurotomy but more severe stenosis and more 
severe pulmonary hypertenwn than older pts. The procedure using the metallic commis- 
surotome appears safe in both groups and leads to similar results at any age. 
1281-109 IO-Year Follow-Up Results of Mitral Balloon Valvotomy in 
500 Consecutive Patients Using lnoue Balloon Technique 
Mohamed E. Fawzy, J. Buraiki, M. Stefadouros, M. Chaudhry, H. Hegazy, M. Awad, 2. Al- 
Halees. King Fake?/ Specialist Hospital. Riyadh, Saudi Arabia 
The long-term results (lo-year) of mitral balloon valvotomy (MBV) has not been well 
characterized. Methods: 500 consecutive patients (pts) aged 31 i-11 (mean i S.D.) 
years underwent MBV for .st?vere mitral stenosis (MS) using lnoue balloon technique over 
a 1 O-year period, clinical evaluation and echocardiographic (echo) examination were car- 
ried out before and immediately after MBV and annually thereafter. Mitral valve morphol- 
ogy (MVM) was w&ted and semiquantitated using Wilkins mitral echo score (MES). 
326 pts have completed i-10.5 (mean 4.8 r 2.9) year follow-up and represent the study 
population. Patients were divided into 2 groups according to MES: Group I (n= 248) 
(MES equal or less 8) and Group II (n = 78) (MES more than 8). Comparison of hemody- 
namic variables was done using student’s t-test, chi-square/Exact-test was used to study 
categorical variables. Logistic regression analysis was used to identify predictors of rest- 
enosis. Event free survival from restenosis was plotted using the Kaplan-M&r test. 
Results: The immediate and long-term hemodynamic results are as follows: (see Table 
1). Logistic regression analysis identified MES and suboptimal result (immediate MVA 
equal or less 1.5 cm2 ) are strong predictor of restenosis (P = 0.007 and 0.04 respec- 
tively). The event free survival for 1, 2, 3, 5, 7, 8, 9, 10 years were 0.99, 0.98, 0.97, 0.9, 
0.79, 0.73, 0.56, 0.56 for Group I and 0.98, 0.92, 0.89, 0.78. 0.63, 0.46, 0.20 for Group II 
respectively Conclusion: Good results were observed LID to 10 war after MBV and , 
unfavourable mitral valve morphology is strong predictor of restenosis. 
Group I Group II P Value 
Mitral mean gradient (mmHg) I3 12.5 + 5.0 12.8 * 4.3 N.S. 
I 4.9213 5.3 f 2.1 N.S. 
F 5.6 f 2.9 5.9 + 2.7 N.S. 
Mitral valve area (MVA) cm2 B 0.9*00.16 0.89 + 0.2 N.S. 
I 2.0 * 0.29 1.82 f 0.27 P less than 0.001 
F 1.8 + 0.4 1.5*0.4 P less than 0.001 
Restenosis 34 (13.8%) 22 (28%) P = 0.004 
B = before MBV; I = immediately after MBV; F = follow-up 
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10:30 a.m. 
Natural History of 610 Adults With Asymptomatic 
Hemodynamically Significant Aortic Stenosis Over 
Prolonged Follow-Up 
Patricia A. Pellikka, Rick A. Nishimura, Kent R. Bailey, Marion E. Barnes, Youssef F 
Malouf, E. Marcony Juracan, Daniel Tiede, Tanya Taylor, A. Jamil Tajik. &yo Clinic, 
Rochester, MN 
Background: In a previous study of 113 patients with asymptomatic, hemodynamlcally 
significant aortic stenosis who were followed for 20 months, we reported that no patient 
had sudden death while remaining asymptomatic. The purpose of the current study was 
to validate this in a larger population with extended follow-up. 
Methods: From 1984 to 1995, 2,853 patients with valvular aortic stenosis and peak sys- 
tolic velocity B 4 misec by Doppler echocardiography were identified. Of these, 2,i 17 
patients were symptomatic at initial evaluation and were excluded. Another 105 patients 
underwent aortic valve surgery within 3 months and were excluded. Of the remaining 631 
patients, follow-up, obtained by review of medical records, death certificates, mailed 
questionnaire, and telephone, was available for 610 patients (97%). 
Results: There were 375 men and 235 women, mean age 71.9 + 11 .I years. Duration of 
follow-up was 5.1 + 3.8 years. Among the 610 patients, the probability of remaining free 
of symptoms of angina, dyspnea or syncope was 85%, 72% and 47% at 1,2 and 5 years, 
respectively. Cardiac death occurred in 25 patients: 13 of these developed symptoms 
prior to death and 12 had no record of having developed symptoms prior to death, 
although medlcal follow-up was limited in most. Surgery (>3 months after initial evalua- 
tion) was performed in 311 patients. The 1, 2 and 5 year probabilities of remaining free 
of aortic valve surgery or cardiac death were 94%, 85% and 62%, respectively. While 
asymptomatic and untreated with surgery, the 1, 2 and 5 year probabilities of remaining 
free of cardiac death were 99%, 99% and 96%. Of all clinical and echocardiographic 
variables, only age at initial evaluation (p < 0.001, RR = 0.98) and non-use of diuretics (p 
= 0.02, RR = 0.50) were independent predictors of subsequent surgery or cardiac death. 
Conclusion: Patients with asymptomatic, hemodynamically significant aortic stenosis 
are at significant risk of developing symptoms within 5 years. During the time they 
remain asymptomatic, cardiac death can occur, but is rare. The asymptomatic patient 
may be observed, but requires careful follow-up for the development of symptoms. 
891-2 
IO:45 a.m. 
The Value of Treadmill Exercise Testing in Apparently 
Asymptomatic Aortic Stenosis 
Paul Das, Helen Rimington, Kelly McGrane, John Chambers. Department of Cardiology, 
Guy’s and St. Thomas’ Hospitals, London, United Kingdom 
Background: The onset of significant symptoms in sevtxe aortic stenosis presages a 
high mortality rate. Despite this, physicians normally rely on subjective patient enquiry 
and little objective data about exercise capacity exist. Method: We therefore studied 58 
consecutive patients aged 65 years (range 32-79 years) with moderate or severe aortic 
stenosis defined by peak transaortic velocity >2.5m/s and normal left ventricular systolic 
function. All denied significant symptoms and were being managed conservatively. Each 
patient completed a Specific Activity Scale (SAS) questionnaire. A full echocardiographic 
study was made. Effective orifice area (EOA) was calculated by the continuity equation. 
Exercise testing was performed using the Modified Bruce protocol, terminated at symtom 
onset or fatigue. Results: Mean transaortic velocity was 3.7m/s (range 2.6.5.7mis). 40 
patients were SAS functional class I and 18 class II. SAS class correlated to age on 
univariate analysis (~~0.05). Mean exercise time was 679 sets for class I patients and 
461 sets for class II (p=O.O004, 95% Cl 102-313). There were no complications during 
exercise testing. On multivariate analysis exercise time correlated inversely to SAS class 
(t=-2.5, p=O.O2), but was not significantly related to age, peak or mean transaortic pres- 
sure drop, EOA or aortic valve resistance. 21 patients (36%) experienced significant 
symptoms during exercise testing (14 breathlessness, 5 chest pain and 2 dizziness). 11 
of these were SAS class I and 10 class II. Conclusions: 36% of patients with aortic 
stenosis who are apparently asymptomatic develop symptoms on treadmill exercise test- 
ing. A structured questionnaire predicts exercise time better than self-reporting but 27% 
of patients in functlonal class I still have exertional symtoms. Treadmill testing is therefore 
an important investigation in aortic stenosis. 
891-3 
II:00 a.m. 
lschemic Mitral Regurgitation: Long-Term Outcome After 
Surgical Correction and Recent Improvement 
Maurice E. Sarano, A. Jamil Tajik. Hartzell V. Schaff Kenton J. Zehr. rylayo Clinic, 
Rochester, MN 
Background: lschemic mitral regurgitation (IMR) is often surgically corrected late in the 
course of disease with ensuing high mortality Determinants and recent improvements in 
long-term outcome are not well defined. 
Methods: Between 1980 and 1995, 227 patients underwent surgical correction of iso- 
lated IMR without papillary muscle rupture (age 68+9 years, 90% in functional class Ill- 
IV). The periods 1980-87 and 1988-95 were compared. 
Results: In multivariate analysis, EF was the main predictor of survival (p<O.OOOl) and 
utilization of IMA for revascularization was independently associated with lower operative 
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mortality (adjusted odds ratio 0.31, p=O.O22), with lower long-term mortality [adjusted risk 
ratio (RR) 0.61, p=O.O2]. Medical treatment (Angiotensin converting enzyme inhibitors, p- 
blockers, or Statins) was also independently associated with improved 5-year survival 
(65&6 “s 46&g%, p=O.O28). 
Conclusions: After surgical correction of IMR, 1) long-term mortality is high and deter- 
mined by left ventricular dysfunction; 2) utilization of IMA is independently associated 
with improved survival, resulting in 3) improved survival and decreased operative mortal- 
ity recently. 4) Vigorous medical treatment also contributes to improved survival. These 
imoroved results mav allow considerina suroical correction of IMR before end-staae heart 
failure develops, to obtain better long-t& &tcome. 
Variables Overall 80-87 88-95 P 
Age 6829 67*9 6919 0.16 
Ejection Fraction (EF) 42il3 40*13 43*13 0.22 
Interal grafting mammary (%, IMA) 33 14 49 0.0001 
Valve repair (%) 63 47 76 0.0001 
Operative mortality 16.7 23.8 10.7 0.008 
1 O-year survival 28~3 25+4 31*5 0.05 
891-4 
Ii:15 a.m 
The Progression of Mitral Valve Prolapse: A Follow-Up 
Investigation in the Framingham Heart Study 
Lisa A. Freed, Emelia J. Benjamin, Daniel Levy, Martin G. Larson, Jane 6. Evans, 
Deborah L. Fuller, Birgitta Lehman, Robert A. Levine. Massachusetts General Hospital, 
Boston, MA, NHLBl’s Framingham Heart Study, Framingham, MA 
Background: Hospital-based studies have iridicated a relatively rapid and severe pro- 
gression of mitral valve prolapse (MVP), but this has not yet been systematically exam- 
ined in the community setting. Using current 2D echo diagnostic criteria, MVP has been 
shown to have a low prevalence and more benign presentation in the Framingham Heart 
Study (FHS). Therefore, we explored the progression of MVP in the FHS sample to deter- 
mine the degree of change of its echo features, including mitral leaflet displacement (D), 
thickness (T), and mitral regurgitation (MR). 
Methods: Subjects (n=72) determined to have MVP by echo measurements from the 5th 
exam cycle of the FHS Offspring cohort were initially classified as classic (D>Zmm, 
TZmm) or nonclassic (D>Pmm, T<Smm). Another 61 subjects had minimal superior 
displacement (MSD)(O<DQmm). Blinded to previous classification, D, T, and MR were 
measured by the same investigator in the same subject at the 6’h exam, 4.1+0.6 years 
later. MR (%jeffleft atrial area) was considered trace, mild, moderate, or severe for ratios 
of >O-10, >lO-20, >20-40, or >40%. Progressive changes of D, T, and MR were examined 
as continuous variables. 
Results: Progression (change from exam 5 subtracted from exam 6, meanistandard 
deviation): 
Classic MVP Nonclassic MSD 
(n=40) MVP(n=32) (n=61) 
AD (mm) 0.2fl.O 0.3?0.6* 0.7fl .l’ 
AT (mm) -O.l_cO.5 0.2-tO.7 0.2?0.9 
AMR (%area) -5.9~16.5*’ -3.5+10.1 -1.5+9.0 
Increase in MR to mild, n(%) 2 (5%) 2 (6%) 1 (2%) 
Increase in MR to moderate, n(%) 2 (5%) 1 (3%) 3 (5%) 
*significant increases, ~~0.05, **significant decrease, ~~0.05 
The degree of displacement increased for nonclassic and MSD subjects. The degree of 
MR decreased for classic subjects, which may reflect regression to the mean. No sub- 
jects developed flail leaflets, new ruptured chordae, or sevvere MR. One subject with clas- 
sic MVP underwent mitral valve replacement. 
Conclusion: In contrast to prior referral-based series, only a small percentage of sub- 
jects with MVP in a community-based sample progress in an important way over a period 
of 4 year?, in terms of increasing degrees of MR, with relatively mild changes in measures 
of displacement and thickness reflecting leaflet degeneration. 
891-5 
11:30 a.m. 
Long-Term Results of Mitral Valve Repair in Patients With 
Infective Endocarditis 
Bernard lung, Juliette Rousseau, Patricia Berdah, Olivier Varenne, Joel Kamblock, 
Philippe Lionet, Bertrand Cormier, Gerard Papouin, Alec Vahanian. Bichat Hospital - 
Cardiology, Paris, France 
Background : The improvements in the techniques of mitral valve repair have extended 
its feasibility in patients (pts) with infective endocarditis. However, mid-term results of 
valve repair using contemporary techniques are not well known. Methods: Between 
1990 and 1999, mitral valve repair was performed in 63 pts who had regurgitation due to 
infective endocarditis. Their mean age was 5Oi17 yrs [15 to 781. Mean left ventricle ejec- 
tion fraction (LVEF) was 61 rll% [25 to 781. Surgery was performed during the acute 
phase in 25 patients (40%), a median of 20 days after the onset of treatment, and later in 
38 patients (60%), after a median of 11 months. The infective micoorganism was strepto- 
coccus in 33 pts (53%), staphylococcus in 10 (16%), other in 4 (6%), and unknown in 16 
(25%). Results : Surgical findings revealed vegetations in 27 pts (43%), leaflet perfora- 
tion in 21 (33%), and valve prolapse in 50 pts (79%), involving the commissural area in 
19 (30%). Valve repair associated annuloplasty in all cases in 61 pts (97%), valve resec- 
tion in 49 pts (78%), shortening or transposition of chord&? in 29 (46%), suture of p&o- 
ration in 18, (29%), pericardial patch in 12 (19%). partial homograft in 7 (11%). 
Associated procedures ware aortic valve replacement in 11 pts, CABG in 3, and tricuspid 
homograft in 1. Complications were : 2 deaths (3%), 1 case of severe MR (3/4) who 
underwent successful w-repair, and 1 case of subsequent aortic endocarditis. The 7.year 
rate of survival with no reoperation and in NYHA class I or II (event-free survival) was 
80+5% in the global series. In multivariate analysis, the 2 predictors of event-free survival 
were hypertension (p<O.Ol) and intervention during the acute phase (p=O.O2). Survival at 
7 years was 96*4% in the patients operated on during the acute phase and 91+5% in the 
patients operated on later (p=O.65). Three pts were reoperated on the mitral valve, 1 for a 
residual regurgitation, 1 for a residual stenosis, and 1 for a recurrent endocarditis. Con- 
clusion: Valve repair gives good results in wide range of patients with infective 
endocarditis. Pts operated on during the acute phase experience more events during fol- 
low-up, but have excellent late survival. 
891-6 
11:45 a.m. 
Echocardiographic Predictors of Mortality in Endocarditis: 
An Analysis of 450 Patients From the Duke Endocarditis 
Service 
Christopher H. Cabell, Gail E. Peterson, Deverick J. Anderson, Vance G. Fowler, Jr., 
Andrew Wang, John K. Harrison, Thomas M. Bashore, Thomas Ryan. Duke University 
Medical Center. Durham, NC, Duke Clinical Research Institute, Durham, NC 
Background: Echocardiography has become an integral part of the diagnostic evalua- 
tion of endocarditis. Little is known about how echo data are used to make therapeutic 
decisions or how findings predict mortality. We evaluated all patients entered into the 
Duke Endocarditis Database to determine echocardiographic predictors of stroke, sur- 
gery, and mortality at 30 days and one year. Methods: The endocarditis service identi- 
fied patients from 1991-1999 with definite or possible endocarditis based on the Duke 
criteria. Data were collected from the patient’s medical record and clinical course. Logis- 
tic regression analyses were used to determine the echo predictors of stroke and sur- 
gery. Cox proportional hazard models were used to determine the independent echo 
predictors of 30 day and one year mortality controlling for stroke and surgery. Results: 
From l/1/91 to 12/31/99 we identified 450 cases of definite or possible endocarditis as 
defined by the Duke criteria. The mean follow up was 2 years; 230 died in the study 
period. The presence of a left sided vegetation (OR 3.5 pc.01) and oscillating vegetation 
(OR 2.2 pc.Oi) were both predictive of stroke while the only independent predictor of 
stroke was the presence of avegetation on the mitral valve (OR 4.6 pc.01). The indepen- 
dent predictors of surgery were severe aortic regurgitation (OR 3.1), prosthetic valve (OR 
2.4) and vegetation (OR 2.0) (pc.01 for all). However, the only echo predictor of non-sur- 
gical management was severe mitral regurgitation (OR 1.4 pc.01). At 30 days the inde- 
pendent predictors of mortality were savera aortic regurgitation, mitral vegetation size 
and oscillating mitral vegetation, while at one year the only independent predictor of mor- 
tality was mitral vegetation size (pc.05 for all). Conclusion: In addition to its diagnostic 
utility, echocardiography is a powerful predictor of outcome in those with endocarditis. 
Echocardiographic information predicts short term complications such as stroke, and 
may influence treatment decisions such as whether to perform surgery. Controlling for 
these events, echo findings, specifically severe aortic regurgitation and mitral vegetation 
size, remained predictive of mortality. 
